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FOREWORD
In an attempt to make this dissertation a continuous and complete 
work, some portions of research were omitted. This Includes 
investigation of structure-function relationships of the enterotoxin from 
Clostridium oerfrinaens. performed under the guidance of Dr. E. W. 
Blakeney, which led to one publication (Salinovich, 0 . ,  (lattice, W .f and 
Blakeney, E. W. 1962. Effects of temperature, pH, and detergents on the 
molecular conformation of the enterotoxin of Clostridium perfrinaens. 
Biochim. Biophys. Acta 707: 147-153). In addition, work leading to the 
development of a novel peptide mapping technique not used directly in my 
dissertation research was also not included (Salinovich, 0. and 
Montelaro, R. C. 1986. Reversible staining and peptide mapping of 
proteins transferred to nitrocellulose after separation by 
SDS-polyacrylamide gel electrophoresis. Anal. Biochem., in press).
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ABSTRACT
Four isolates of equine infectious anemia virus (EIAV) recovered 
weeks apart from a single experimentally infected Shetland pony (Orrego, 
1983) were examined in both antigenic and structural analyses to 
investigate variation occurring during persistent Infection. These four 
isolates were shown to be antigenically distinct in both serum 
neutralization assays and in immunoblot analysis with either a polyclonal 
equine reference antiserum or a panel of virus-specific monoclonal 
antibodies. Two-dimensional mapping of tryptic peptides of viral 
components from these isolates revealed that both gp90 and gp45 undergo 
structural variation during virus replication in a single animal, but that 
no such structural variation occurs in the internal proteins p26, p i5, or 
p9. Through the use of a novel two-dimensional mapping technique 
developed for analysis of tryptic glycopeptides, it was demonstrated that 
structural variation also occurs in the glycopeptides of both gp90 and gp45 
during persistent infection.
A panel of nine EIAV Isolates recovered from two Shetland ponies 
infected in parallel with the same EIAV inoculum were examined by the 
same antigenic and structural analyses to investigate the extent of 
variation possible. Although antigenic studies of these isolates were 
limited, the nine EIAV isolates together with the prototype strain
ix
represent at least seven distinct serotypes. All ten EIAV strains were 
shown to structurally distinct by virtue of peptide and glycopeptide 
alterations in both gp90 and gp45. No pattern of evolution of variation was 
evident by comparison of the nine isolates from the two parallel 
Infections, indicating that a relatively large number of distinct EIAV 
variants may be possible.
Hydropathic character and general conformation of the gp90 and gp45 
polypeptides were accomplished by computer analysis of the amino acid 
sequence of the envelope polyprotein, as predicted from the nucleic acid 
sequence of the proviral env gene (Rushlow et a l., 1986). The results 
predict that gp90 is a relatively hydrophilic, globular protein with 13 
potential glycosylation sites evenly distributed throughout the molecule. 
The gp45 polypeptide is relatively hydrophobic with four of five possible 
glycosylation sites localized to the N-terminal region, and contains four 
possible transmembrane regions. It appears from the conformational
analysis that an extensive region of P-sheet may exist at the c-terminus of 
gpQO and the N-terminus of gp45, thus forming an area of Interchain 
hydrogen bonding responsible for the close association of these two 
molecules In the mature virton. By combining all predicted structural 
features, it was possible to construct a model of the gp90/gp45 complex. 
This model may serve as a reference for the production of effective 
vaccination protocols against this economically Important virus.
x
CHAPTER 1 
INTRODUCTION
EQUINE INFECTIOUS ANEMIA: THE DISEASE
Equine infectious anemia (EIA) is an acute hemolytic disease caused by 
a nononcogenic retrovirus and occurs worldwide in members of the family 
equidae (Charman et a l . , 1976; Cheevers et a l . , 1977; Issel and Coggins, 
1979). Although one of the first diseases shown to be caused by a virus 
(Vallee and Carre, 1904), very little was known about the molecular 
characteristics of the virus or the disease until the last five to ten years. 
In the United States, Louisiana has the highest reported incidence of the 
disease. About 5% of the horses sampled between 1976 and 1981 in this 
state tested positive for EIA, although it is believed that in some areas of 
Louisiana the infected population may be as great as 30 to 40% (Foil and 
Issel, 1982).
Clinical Symptoms
EIA is unique among retroviral-induced diseases because of its 
episodic nature (Crawford et a l . , 1978; Issel and Coggins, 1979; Orrego et 
a l . , 1982). After infection, the disease occurs in unpredictable bursts of 
clinical symptoms and plasma viremia separated by weeks or months, 
between which the animal may be clinically normal. Individual responses 
to infection by natural or artificial routes are variable and may depend in
1
2part on host resistance factors, relative virulence of the infecting virus, 
or environmental stresses. Infected horses may exhibit acute, chronic, 
or inapparent stages of the disease, as depicted graphically In Figure 1.
Acute EIA - -  This form of the disease Is usually associated with the „ 
first exposure to the virus and results from massive virus replication in 
infected macrophages and subsequent cell destruction. Clinical symptoms 
include hemorrhages and fever. Anemia and edema are not 3een in this 
stage of the disease.
Chronic EIA — Animals with chronic EIA exhibit characteristic episodic 
bursts of clinical symptoms, such as weight loss, anemia, lethargy, 
subcutaneous edema, leukopenia, and central nervous system 
depression, as well as fever and hemorrhages (Orrego et a l . , 1982).
Inapparent EIA — Animals in this stage of the disease exhibit no 
clinical symptoms, and are apparently healthy. However, they harbor the 
virus for life, and although asymptomatic, virus or viral products can be 
detected in the blood of such animals (Kemen and Coggins, 1972; Issel et 
a l. ,  1982).
infected animals may exhibit one or more of these disease stages.
Some suffer chronic EIA, with episodes of increasing severity, until 
finally succumbing to the disease. In most cases animals experience 
several recurring disease episodes, after which they become inapparently 
infected carriers. Such animals may remain asymptomatic for the rest of 
their natural lives, or chronic EIA may return after such environmental 
stresses as overwork or other disease infections. Recurring episodes
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Figure 1. Schematic representation of the different disease stages 
observed in animals with equine infectious anemia.
4may also be induced in inapparently infected animals by injection with 
immunosuppressent drugs (Orrego et a l . f 1982). Occasionally, affected 
horses undergo only the initial febrile attack, and remain asymptomatic 
for life. Since symptoms during initial infection are sometimes rather 
mild in these cases, the disease may be overlooked, and these animals 
become serious threats to uninfected animals as unidentified carriers of 
EIA.
Transmission
Transmission of EIA is mainly horizontal and only rarely vertical. 
Horizontal transmission is commonly the result of hematophagous 
arthropod insects, feeding on horse blood (issel and Coggins, 1979; Foil 
and Issel, 1982; Williams et a l., 1981), or from the use of contaminated 
instruments or syringes, thus transferring infective blood or blood 
products (Issel and Coggins, 1979). The potential for transmission from 
an infected donor appears to be higher in the presence of clinical signs 
than in the absence and seems to correlate directly with the level of free 
virus in the donor's blood and tissues. The virus can apparently cross the 
placental barrier and cause fetal infection, although more than 75% of the 
foals born to infected mares can be raised free of EIA (Kemen and 
Coggins, 1972; Foil and Issel, 1982).
Diagnosis and Control
EIA can be diagnosed on the basis of its characteristic clinical signs, 
hematology, or pathology. Clinical signs, however, are not always 
definitive, therefore specific laboratory tests are necessary and
5important to the diagnosis of this disease. Such tests usually involve the 
detection of virus or EIA specific antibody in the suspected animal.
One such test demonstrating the presence of virus in the blood of an 
animal is the horse inoculation test, which 1s performed by injecting its 
blood into a susceptible horse. Development of disease in the recipient 
animal indicates the presence of virus in the donor horse. In addition to 
being expensive, time consuming, and wasteful, it is often difficult to 
Interpret the clinical signs of the recipient.
Several serological tests have been developed for diagnosis and 
research of EIA infection. These include the complement fixation test 
(Kono and Kabayashi, 1966), the serum neutralization test, and the agar 
gel Immunodiffusion (AGID) test (Roth et a l., 1971; Coggins et a l., 1972). 
The AGID test, which is widely used in the diagnosis of EIA, allows for 
reliable and sensitive detection of EIA specific antibody in the serum of a 
suspected animal. Although a correlation between precipitating antibody 
and EIA viremia has been demonstrated (Coggins et a l., 1972), the AGID 
test, as with any serological test to detect antibody, cannot detect the 
phase of infection prior to antibody production nor distinguish whether or 
not there is active replication of virus in the animal.
More sensitive serological tests, such as Immunofluorescence 
(Crawford et a l . , 1971), radioimmunoassay (Coggins e ta l . ,  1978), and 
enzyme linked immunoassay (Shane et a l. ,  1984), have been developed to 
detect EIAV antigen or antibody. These tests can aid in the diagnosis of 
those cases in which AGID titers are extremely low.
6Since prevention or treatment of EIA has not yet been successful, 
efforts to control this disease have mainly involved screening for EIA and 
subsequent regulation of transportation and housing of EIA positive 
animals.
EQUINE INFECTIOUS ANEMIA VIRUS: THE CAUSATIVE AGENT
Equine infectious anemia virus (EIAV) is a member of the retrovirus 
family of RNA viruses. These viruses have been isolated from a diverse 
group of animals and are capable of producing a wide array of oncogenic, 
nononcogenic, and progressive diseases. Characteristics common to all 
retroviruses include the nature of their genomes, their mechanism of cell 
entry, their structure, and their mode of replication through a DNA 
intermediate. This last attribute distinguishes this virus family from 
other RNA viruses, such that any virus utilizing a virus-coded 
RNA-directed DNA polymerase for replication of its genome is included in 
the retrovirus family. Common taxonomic features of the family 
Retroviridae are summarized in Table I.
EIAV has been shown to exhibit many of the properties common to 
retroviruses. Virus particles have a buoyant density of 1.15 -  1.16 g/ml 
at 20°C, and a general spherical shape of 80 -  120 nm diameter (Charman 
e ta l. ,  1976; Parekh et a l . , 1980). These particles possess a central 
core or capsid containing 8 ribonucleoprotein complex. The virus 
contains a 60 -  70S RNA genome, composed of two identical single 
stranded subunits of 34S and the virus-derived reverse transcriptase
7Table I .  Taxonomic characteristics common to members of the family 
Retroviridae.®
Morphology Spherical enveloped virions(8 0 - 120 nm in diameter), 
variable surface projections (8  nm), icosahedral or 
cubic capsid containing a ribonucleoprotein complex
Physicochemical
properties
Density 1.16 to 1.18g/ml in sucrose, 1.16 to 1.21 
g/ml in cesium chloride, sensitive to lipid solvents, 
detergents, and heat Inactivation (56°C, 30 m1n), 
highly resistant to UV and X-radiation
Nucleic acid Linear posltive-sense single-stranded RNA (60 to 70 S) 
composed of 2 identical subunits (30 to 35 S), 5‘ cap 
(M7G^ppp^NpNp), polyadenylated 3* end, 1% by weight
Protein* About 60% by weight; gag, internal structural proteins 
(4 to 5); pol% reverse transcriptase and protease (1 to 
2 ); env> envelope proteins (1 to 2 )
Lipid About 35% by weight, derived from cell membrane
Carbohydrates About 4% by weight, associated predominantly with env 
proteins
Sfrom Teich (1982), and Bharat Parekh, Ph.D. dissertation, Louisiana 
State University, 1983
*The figures in brackets indicate the number of resultant polypeptides.
8(Charman et a l . , 1976; Cheevers et a l . , 1978). EIAV is sensitive to ether 
and detergents, or any reagents which disrupt the lipid envelope.
V1ru3 Morphology
The general structure of retroviruses has been investigated by 
electron microscopy (Bernhard et a l . , 1958; Gross, 1970; Vigier, 1970). 
Most retroviruses are roughly spherical, and about 100 nm in diameter. 
They consist of an outer lipid membrane, which is derived from the host 
cell, surrounding a core of either icosahedral or cubic symmetry. The 
envelope possesses numerous spikes and knobs, consisting of 
glycosylated proteins (Rifkin and Compans, 1971). Retroviruses can be 
divided into four morphologic categories, according to minor differences 
revealed by electron microscopy: type-A, type-B, type-C, andtype-D 
particles (Bernhard, 1960; Sarkar et a l . , 1972; Fine and Schochetman, 
1978). These differences are associated with the location of the inner 
core within the envelope, presence or absence of visible Intracellular or 
extracellular viral particles, and appearance changes during the process 
of budding from the host cell membrane.
Electron micrographic studies of EIAV revealed spherical particles of 
8 0 -  120 nm diameter, with rod- or cube-shaped electron-dense 
nucleoids, 40 -  60 nm in length or diameter (Weiland et a l . , 1977; Teich, 
1982). Thin surface projections or spike-and-knob structures were 
observed on the membrane surface, and in some cases an inner shell or 
coat was also observed. EIAV buds from the host cell plasma membrane
9following the appearance of cresent-shaped or semicircular cores 
beneath the membrane. The electron-lucent region between the core and 
the lipid bilayer that is typical of type-C retroviruses was not evident in 
mature virions. Thus EIAV most closely resembles vlsna virus or human, 
T-cell lymphotropic virus type ill/lymphadenopathy virus (HTLV-111/LAV) 
morphologically, and is distinct from type B, C, or D retroviruses (Gonda 
et a l., 1985).
Virus Replication
As mentioned above, one of the unifying characteristics of 
retroviruses is the mode of replication. The simplest representation of 
this replication can be given as
RNA -* DNA-+ RNA (-> protein) 
where the first step Is performed by a virus-coded, RNA-dlrected DNA 
polymerase which is carried in the infectious virion, and the subsequent 
step(s) performed by host enzymes.
Retroviruses usually establish themselves stably into the cells they 
infect, and this is accomplished by covalent integration of a double 
stranded retroviral DNA copy into the host cell’s chromosomal DNA. 
Several intermediate DNA molecules 8re synthesized from viral RNA, 
leading to the integrated provirus. A schematic view of the major events 
In this replication cycle are depicted in Figure 2 (Varmus and Swanstrom, 
1982). Transcription of provirsl DNA results in at least two mRNA 
species, a larger species serving as message for translation of the gag 
and pol genes, and a smaller species coding for the env genes. The
10
Figure 2 . A simplified schematic representation of replication and 
integration of the retrovirus genome. 1. Viral RNA*. Rg»R3 “ 5’ and 3'
terminal repeats; 1)5,113 = 5' and 3' untranslated regions; PB = primer
binding site; 6 , P, and E ■ gag, pol, and env genes, respectively. 2 and 
3. cDNA and double stranded DNA synthesis. 4. Circular double stranded 
viral DNA. 5. Integration of viral DNA into host genome. 6 .
Transcription of proviral DNA to yield mRNAs and viral RNAs.
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large RNA species is also the viral genome which is packaged into progeny 
virus.
Stable integration of EIAV proviral DNA into the host cell genome has 
been demonstrated in persistent nonlytlc infection of equine fibroblasts In 
tissue culture (Crawford et a l . , 1978; Rice et a l . , 1978), as detected by 
hybridization studies with cDNA synthesized from viral RNA. These studies 
revealed an average of two to six complete DNA proviral sequences per 
haplold genome. There was no detectable hybridization of EIAV cDNA with 
normal horse DNA, indicating that it is not an endogenous virus of the 
horse. In addition, no ElAV-related sequences were found in the DNA from 
other Equus species or in a variety of other mammals, nor would EIAV 
cDNA hybridize with a variety of other retroviruses.
Virus Polypeptides and Their Location
Studies involving identification of viral polypeptides by high resolution 
sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
and guanidine hydrochloride gel filtration techniques have been performed 
for many retroviruses, including EIAV (Montelaro et a l.,  1978; Parekh et 
a l. ,  1980; Montelaro et a 1., 1982). In addition, localization studies have 
provided information about the organization of these polypeptides within 
the virion. The results of these studies for the prototype-C mammaltan 
retrovirus Friend murine leukemia virus (FLV) and the avian counterpart 
Rous sarcoma virus (RSV) are given in Table II, along with the results 
obtained for EIAV.
Surface labeling and careful digestion of intact virions revealed two
13
Table I I .  Structural components of avian and murine type-C 
retroviruses, as well as EIAV
Virion polypeptides Structural Virion
Avian Murine EIAV Component Structure
gp85 gp7i gp90 Knob Envelope
gp35 p!5E gp45 Spike Envelope
pp19 pp!2 ppl5 Inner coat Inner coat
p27 p30 p26 Core shell Core
pi 5 p15C p9 Core associated Core
P1Z pi 0 Pi 1 Nucleoproteln Ribonucleoprotein
complex
Montelaro and Bolognesf (1980) 
Montelaro et al. (1982)
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surface polypeptides associated with the lipid envelope, one or both of 
which are glycosylated (Cheevers et a l. ,  1980; Mosser et a l.,  1977; 
Montelaro et a l . , 1982). These comprise the knob-and-splke structures 
seen in electron micrographs, with the larger more hydrophilic 
component (gp85, gp71, or gp90) forming the knob and the smaller more 
hydrophobic component (gp35, p15E, or gp45) forming the spike which 
may span the lipid btlayer. These two surface components may or may not 
be linked covalently by disulfide bridges, depending on the particular 
virus. No such disulfide bridges between the gp90 and gp45 components of 
EIAV appear to exist (Montelaro et a l . , 1982).
Analysis of subvlral particles derived by partial disruption of intact 
virions demonstrated that the core structure seen in electron 
micrographs consists mainly of the most abundant nonglycosylated 
polypeptide of the virion (p27 for the avian case, p30 for the murine case, 
and p26 for EIAV), and a smaller, highly basic polypeptide (Davis and 
Rueckert, 1972; Schafer and Bolognesi, 1977; Montelaro et a l . , 1982). 
These cores are of icosahedral symmetry in the murine retrovirus, and 
are cube-shaped in EIAV. Further disruption of the cores releases a 
rlbonucleoproteln complex consisting of the RNA genome and a highly basic 
polypeptide, along with the reverse transcriptase (Bolognesi, 1974; Davis 
andRueckert, 1972; Montelaro et a l . , 1982). The basic component in the 
avian virus is p12, in the murine virus it is p10, and in EIAV it is pi 1.
Electron microscopic studies of these retroviruses demonstrated a
15
thin layer just beneath the viral envelope, designated the inner coat. The 
major phosphoprotein found in these retroviruses was not present in the 
core structure and was not detectable at the virus surface (Schafer and 
Bolognesi, 1977; Montelaro et a l . , 1982). In the avian virus, the pp19 
component could be crosslinked to gp35 in intact virions treated with 
reversible crosslinking reagents. Thus these phosphoproteins (pp19 in 
the avian virus, pp12inthe murine virus, and pp15 in EIAV) are thought to 
comprise this inner coat.
With the information from both electron microscopy and the 
localization experiments, a tentative model of the intact EIAV virion has 
been proposed, as shown in Figure 3 (Montelaro et a l . , 1982). The gp90 
and gp45 components, coded by the env gene of viral RNA, comprise the 
knob and spike structures, respectively, found on the virion surface. A 
thin inner coat composed of the phosphoprotein ppl 5 is located just 
beneath the lipid envelope, which is derived from the host cell membrane 
during budding. The core shell Is composed of the major nonglycosylated 
polypeptide p26. This core shell surrounds the positive-sense RNA 
genome and its closely associated basic polypeptide pi 1. The reverse 
transcriptase i3 also associated with this ribonucleoprotein complex. The 
last remaining nonglycosylated polypeptide of EIAV, p9, has not been 
definitively located, but is shown as associated with the core structure 
since it cannot be found either at the virion surface or in association with 
the ribonucleoprotein complex.
gp90
gp45
Figure 3 . Proposed structure and organization of EIAV.
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CLASSIFICATION OF EIAV AS A LENTIVIRUS 
Subfamilies of Retroviridae
The retrovirus family has been further divided into three subfamilies: 
oncovirlnae, lentlvirinae, and spumavtrinae. The criteria for 
classification is based in part on cross-reactivitiy of the group-specific 
major antigen within a subfamily, and in part on the characteristics of the 
disease the virus induces in infected animals.
Oncovirinae includes the oncogenic and serologically related 
nononcogenic retroviruses, non-infectious replication-defective 
oncoviruses, snd those retroviruses which are difficult to classify. 
Members of this subfamily include the murine leukemia and sarcoma 
viruses, the avian leukemia and sarcoma viruses, and bovine leukemia 
virus. Human T-cell leukemia virus types I and II (HTLV-I and HTLV-II) 
have also been tentatively placed in this group (Poiesz et a l . , 1980; 
Kalyanaraman et a l . , 1982).
Spumaviruses, or foamy viruses, have been Isolated from a number of 
mammalian species, and establish persistent infections without evidence 
of pathogenesis. These viruses induce a characteristic foamy 
degeneration of infected cells in tissue culture after a few weeks. 
Members of this subfamily include simian foamy virus (Rabin et a l. ,  1976) 
and bovine syncytial virus (Malmquist et a l . , 1969).
Lentiviruses cause slow, nononcogenic infections characterized by a 
prolonged incubation period and a protracted symptomatic disease phase. 
Originally, classification of a virus in this group was based more heavily
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on the nature of the Induced disease than on group-specific antigen 
cross-reactivity. Most recently, with the advent of efficient molecular 
cloning and nucleic acid sequencing technology, classification of a 
retrovirus as either an oncovirus or lentivirus has been greatly aided by 
determination of genomic organization (Sonigo et a l . , 1985; Gonda et a l . , 
1985). Members of this group include visna/maedi virus and progressive 
pneumonia virus (PPV) of sheep, and caprine arthritis encephalitis virus 
(CAEV) of goats. EIAV was first tentatively Included In this group because 
of the chronic nature of its induced disease and virus morphology 
(Charman et al. 1976;Parekh e ta l . ,  1980; Montelaro et a l . , 198Z), but 
no antigenic relatedness could be established between this virus and the 
prototype lentivirus vlsna virus (Stowrlng et a l.,  1979). Recent studies 
of the genomic organization of EIAV has shown remarkable relatedness to 
both visna virus and CAEV (Chiu et a l . , 1985; Stephens et a l . , 1986; 
Rushlow et a l . , 1986), thus substantiating its classification as a 
lentivirus. HTLV-lll/LAV, the causative agent of acquired immune 
deficiency syndrome (AIDS), has been included in the lentivirus subfamily 
because of its genomic organization and the progressive nature of the 
disease (Gonda et a l . , 1985). In addition, it has been demonstrated that 
the gag and pot genes of EIAV, visna virus, and HTLV-111 share a high 
degree of sequence homology (Stephens, et a l . , 1986).
Classification of retroviruses by virtue of their genomic organization is 
based on the presence of several small open reading frames in addition to 
the gag% pot,\ and env genes in lentivlruses, which are absent in
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oncoviruses (Ratner et a l . , 1985; Sanchez-Pescador et a l . , 1985; 
Wain-Hobson et a l . , 1985; Sonigo et a l . , 1985; Rushlow et a l . , 1986). 
These short open reading frames (ORF's), which are usually located 
between the pol and env genes and at the 3* end of the env gene, may 
code for short polypeptides which are responsible for the distinct 
pathogenesis of these viruses. In fact, it has been demonstrated that the 
open reading frame between the pol and env genes of HTLV-lll/LAV is a 
crucial part of the spliced gene responsible for the transactivating 
activity of this virus (Sodroski et a l . , 1985; Ayra et a l . , 1985). A major 
factor confirming the classifiaction of EIAV as a lentivirus is the presence 
of these short ORF's, now a distinctive characteristic common to viruses 
of this subfamily (Rushlow et a l . , 1986).
ANTIGENIC VARIATION: MECHANI5M FOR VIRAL PERSISTENCE?
One of the unique qualitites of EIAV is its ability to persist in the 
infected animal in the face of an apparently competent immune response. 
Kono et al. (1973) postulated that the virus isolate associated with each 
disease episode in an animal was antigenically distinct, thus 
circumventing the neutralizing antibody produced against previous virus 
isolates. Evidence supporting this hypothesis was finally presented by 
Montelaro et al. (1984a) In antigenic and structural studies of EIAV 
isolates recovered months apart from different animals during back 
passage of the virus in Shetland ponies. A panel of five isolates, obtained 
from three different animals, were demonstrated to be antigenically 
distinct in neutralization assays, in addition, structural differences were
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revealed in the major surface antigen gp90 from these isolates by 
two-dimensional tryptic peptide mapping. This marked the first time that 
antigenic variation and concurrent structural changes in the major EIAV 
antigen had been demonstrated.
From these and earlier findings, it has been postulated that upon initial 
infection by EIAV and subsequent plasma viremia, the infected animal 
raises an apparently competent immune response and is able to clear 
most of the virus (Figure 4 ). The animal then remains apparently healthy 
until an antigenic variant of EIAV arises, causing a second burst of plasma 
viremia and associated clinical symptoms. Antibody raised against the 
original virus strain does not recognize the antigenic variant, so the 
animal must mount a separate Immune response against It. This cycle 
continues, until the animal dies or becomes an inapparent carrier.
Several major questions remain unanswered about this hypothesis. 
First, where is the virus sequestered after the initial, apparently 
competent Immune response? Also, how are the antigenic changes 
introduced into the virus? What is the extent of this variation from one 
strain to the next? How many different serotypes of EIAV are possible?
Very little is known about the exact target cells for replication of 
EIAV. Early studies demonstrated that monocytes and macrophages are 
the only known cells in horses in which EIAV replicates, and these cells 
are the most readily permissive cells in vitro (McGuire et a l . , 1971; 
Ushimi et a l. ,  1972). The closely related lentivirus, visna virus, 
initially infects monocytes and macrophage precursors, but the virus is
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Figure 4 . Schematic representation of the sequence of events in an 
animal with chronic EIA.
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resticted at the level of transcription in these cells (Gendelman et a l . , 
1985). However, upon maturation of the infected monocytes to 
macrophages, this transcriptional restriction is somehow removed, and 
active replication of the virus takes place. A similar phenomenon may 
occur during EIAV infection.
Recently, RNase Tj-resistant oligonucleotide mapping analysis of five
EIAV isolates demonstrated that distinct genomic changes had occurred In 
these antigenic variants (Payne et a l . , 1984). Similar results have been 
obtained for visna virus, where both genomic changes and structural 
differences in the surface antigen gpl35 have been observed in distinct 
antigenic variants (Scott et a l . , 1979; Clements et a l . , 1980). For both 
of these lentlviruses, the relatively small number of genomic changes 
observed were consistent with the occurrence of point mutations, possibly 
arising during reverse transcription of the RNA genome. Recombinational 
events, such as occur in the emergence of replication-defective highly 
oncogenic sarcoma viruses (Elder et al. 1977a; Rosner a ta l. ,  1980), 
would result in large differences in the RNA genomes. In addition, no 
endogenous retroviral sequences have been found in horse chromosomal 
DNA with which such recombination in EIAV could occur (Rice et a l . ,
1978). In the case of visna virus, the observed genomic changes In 
isolates from the same animal appear to be cumulative (Clements et a l . , 
1982). In contrast, the genomic changes seen in EIAV isolates appear to 
arise from the presence or absence of a specific subset of 
oligonucleotides (Payne et a l . , 1984). Thus, although both viruses
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appear to undergo genomic variation by the introduction of point 
mutations, the mechanism be which these mutations arise may by very 
different.
The extent of variation possible between two successive 8ntfgenic 
variants of EIAV has not yet been determined. Previous studies 
demonstrated structural changes 1n the polypeptide portion of the surface 
antigen gp90, but no information was gained about the contribution of 
carbohydrate to this variation, or if variation was also present In the 
second surface antigen gp45 (Montelaro et a l.,  1984a). Since 
approximately 10 to 15% of the host's immune response to gp90 is directed 
toward the carbohydrate of this molecule, variation in glycosylation 
should be investigated. Contribution of glycosylation to possible variation 
in glycoprotein antigens has become increasingly important, since ft was 
shown that a single amino acid change in the hemagglutinin (HA) of H5N2 
avian influenza virus eliminated a single glycosylation site, thus 
eliminating one of five mapped antigenic sites of this molecule (Kawaoka et 
a l., 1984). This change is believed to be responsible for the 
transformation of an avirulent influenza strain to a very virulent form. 
Also, it has recently been shown that glycosylation can mask or protect 
highly antigenic sites on the peptide backbone of some retroviral antigens 
(Alexander and Elder, 1985), thus lowering the affinity of induced 
antibody in the infected host. Thus, the relatively heavy glycosylation 
seen in the major surface antigens of most lentiviruses may be 
responsible in part for persistence of these viruses in the infected host
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(Sonigo et a l. ,  1985;Ratner, e ta l . ,  1985; Sanchez-Pescador et a l . , 1985; 
Rushlow et a l.,  1986).
The number of antigenically distinct serotypes of EIAV occurring in 
natural Infections has not yet been determined. Previous Investigations „ 
have demonstrated at least five distinct serotypes produced by 
experimental serial passage of the cell-adapted EIAV strain in Shetland 
ponies (Orrego et a l. ,  1982; Montelaro et a l. ,  1984a; Payne et a l.,  1984). 
An estimation of the number of Infection-competent serotypes and the 
extent of structural variation between these serotypes is necessary 
before effective vaccine development can be accomplished. In the worst 
situation, EIAV may resemble the rhinoviruses, which exist in at least 120 
distinct serotypes (Cooper et a l. ,  1978), In which vaccine development 
would be almost impossible.
RESEARCH OBJECTIVES
The main objective of the present research is to address some of the 
unanswered questions of variation In EIAV. These objectives are listed 
below, along with their relative significance.
1) Can structural variation be observed in antigenic EIAV variants 
recovered only weeks apart from a single animal? The extent of 
structural variation necessary to produce an antigenically distinct strain 
capable of circumventing the host's Immune defenses can be estimated. 
Also, the method by which this structural variation arises in EIAV may be 
examined.
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2) Is structural variation limited to gp90, or does the second surface 
antigen gp45 also contribute to this variation? Examination of the gp45 
component of EIAV isolates by two-dimensional tryptic peptide mapping 
has been previously hampered by very high background and low yields of 
this glycoprotein (Montelaro et a l . , 1984a). Thus it is not known whether 
this second surface antigen also contributes to antigenic and structural 
variation in EIAV.
3) What Is the contribution of glycosylation to antigenic and structural 
variation in EIAV? The importance of glycosylation to antigenic properties 
of glycoproteins is becoming increasingly evident, as discussed in the 
previous section. It is therefore important to devise procedures whereby 
the general glycosylation patterns of the two surface glycprotelns gp90 
and gp45 from EIAV antigenic variants can be compared, thus determining 
the contribution of glycosylation in EIAV variation.
4) How many serotypes of EIAV may exist, and what is the extent of 
structural variation between these serotypes? Is there a predictable 
pattern to the evolution of EIAV variants? Such information is vital to the 
future development of successful vaccination protocols for control of this 
economically important disease.
5) What structural features of the surface antigens gp90 and gp45 can 
be determined by computer modeling of the proposed 8mino acid sequence 
for these two components? Through this modeling, some region or 
regions of these molecules may be determined as essential for infectivity 
of EIAV, and thus may be used as targets for the production of synthetic
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vaccines.
The first three points were examined through structural analysis of the 
polypeptide components of four EIAV isolates recovered four to eight 
weeks apart from a single experimentally infected animal. 
Two-dimensional tryptic peptide mapping was performed according to 
established procedures (Elder et a l . , 1977b; Montelaro et a l . , 1984a) for 
the three internal polypeptides p26, p i5, and p9, as well as the 
glycoprotein antigen gp90. Methods for the Isolation of gp45 for 
subsequent mapping were improved, such that it could be included in the 
analysis. In addition, modifications to the two-dimensional mapping 
procedure have been developed such that glycosylated peptides could be 
examined.
Similar structural analysis was also performed on five additional EIAV 
strains recovered from a parallel experimental infection, such that a 
total of nine isolates (in addition to the cell-adapted strain) were 
examined. The isolates recovered from the two parallel Infections were 
compared to determine if any predictable pattern of variant emergence 
could be identified. In this wsy, an estimation of the total variation 
possible in EIAV was accomplished.
Finally, the amino acid sequence of the two surface antigens gp90 and 
gp45, as predicted from proviral DNA sequencing (Rushlow et a l . , 1986), 
was subjected to extensive computer modeling to determine important 
structural features of these two glycoproteins. Location of glycosylation 
sites, hydropathic character, and prediction of secondary structure by
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the procedures of Chou and Fasman (1974, 1978) were performed. This 
information, coupled with known properties of analogous glycoproteins 
from related lentiviruses, revealed important features which may be 
necessary to the infectivity of EIAV.
CHAPTER 2 
MATERIALS AND METHODS
Reagents
A list of chemicals used throughout this study, including sources of 
supply and abbreviations, is given below.
acetic acid -  J.T. Baker; acetonitrile (HPLC grade) -  J.T. Baker; acid
fuschin -  Sigma; cq-acid glycoprotein -  Sigma; acrylamide -  Biorad; 
ammonium acetate -  Sigma; ammonium bicarbonate -  Sigma; ammonium 
persulfate -  Biorad; Autofluor- National Diagnostics Lab.;
1.4-bis-[2-(4-methyl-5-phenyloxazolyl)]-benzene (POPOP) -  Packard; 
bovine serum albumin (BSA) (fraction V, lyophilized) -  Sigma; 
bromophenol blue -  Sigma; 1-butanol -  J.T . Baker; cellulose-coated thin 
layer plates (0.1 mm thickness; 20 x 20 cm) -  E. Merck; chloramine-T -  
Sigma; coomassie brilliant blue R-250 -  Biorad; concanavalin 
A/Sepharose 4B conjugate -  Sigma; 7-deoxycholate (sodium salt)'(DOC) -  
Sigma; diphenyl carbamyl chloride (DPCC)-treated trypsin -  Sigma;
2.5-diphenyloxazole (PPO) -  Packard! Eagle's minimal essential medium 
(MEM) -  GIBCO Lab.; ethanol (absolute) -  Midwest Solvent Co.; ethylene 
diamine tetraacetic acid (EDTA) -  Sigma; ethylene glycol -  J.T. Baker; 
fetal bovine serum -  GIBCO Lab.; fetuin (bovine) -  Sigma; 
[^Hl-glucosamine -  NEN; glucose -  Sigma; glycerol -  Sigma; glycine -
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Sigma; guanidine hydrochloride -  Sigma; N-2-hydroxyethylpiperizine-N'- 
2-ethane sulfonic acid (HEPES) -  Sigma; lentil lectin/Sepharose 4B 
conjugate -  Sigma; 2-mercaptoethanol -  Sigma; 3-mercaptopropionic 
acid -  Sigma; methanol -  J.T. Baker; N,N’-methylene blsacrylamide -  
Biorad; a-methyl glucoside -  Sigma; 2-methylnaphthalene -  Aldrich; 
neuraminidase (Type X from Clostridium oerfrinoens) -  Sigma; 
nitrocellulose membrane (0.45 pm) -  Millipore; nonidet P-40 (NP-40) -  
Particle Data Lab., Inc.; orange 6 -  Sigma; penlctllfn 6 -  Pfizer; pyridine 
-  J.T . Baker; Sephadex G-25 (20-80 Mm) -  Sigma; sodium bicarbonate -  
Sigma; sodium chloride -  MCB; sodium dodecyl sulfate (SOS) -  Biorad; 
sodium hydroxide -  MCB; sodium iodide -  Sigma; I^ 5 |]_ 30C^ um iodide -  
ICN; sodium metablsulflte -  MCB; sodium phosphate (dibasic) -  Sigma; 
sodium phosphate (monobasic) -  Sigma; soybean trypsin inhibitor -  
Sigma; streptomycin sulfate -  Pfizer; N,N,N',N'-tetramethylene diamine 
(TEMED) -  Biorad; 2 ,6 ,1 0 ,14-tetramethyl pentadecane (Pristane) -  
Aldrich; trichloroacetic acid (TCA) -  J.T. Baker; trlfluoroacetlc acid 
(TFA) -  J.T. Baker; tris( hydroxy methyl) aminoethane (Tris) -  Sigma; 
triton X-100 -  Sigma; urea -  Biorad; water (HPLC grade) -  J.T. Baker; 
xylenes -  ASP.
Virus propagation and purification
The cell-adapted Wyoming strain of EIAV (Malmquist et a l . , 1973) wss 
propagated in primary fetal equine kidney (FEK) cells maintained In 
Eagle’s minimal essential medium (MEM) supplemented with 5 to 10% fetal 
bovine serum, 25 mM HEPES buffer, 10 mM sodium bicarbonate, 100 Units
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of penicillin G per ml, and 100 jig streptomycin sulfate per ml (Amborskl 
et a l. ,  1979). This cell-adapted strain will be referred to as prototype 
EIAV. Persistently infected FEK cell3 were maintained as confluent 
monolayers at 37°C In roller bottle cultures (850 cm2) containing 50 ml e 
of medium. Under these conditions virus production continued for 6 to 8 
weeks, until cell senescence.
Supernatant medium was harvested every 3 days for virus purification. 
After removal of medium from the cultures, all subsequent steps were 
performed at 4°C. The medium was first clarified of cellular debris by 
centrifugation in a Sorvall GSA rotor at 9500 rpm (12,000 xg ) for 15 min 
followed by 10- to 40-fold concentration using a Pellicon membrane filter 
cassette system (nominal exclusion 106 daltons molecular weight) 
(Millipore Corp., Bedford, Mass.) .  Virus was recovered from the 
concentrated medium by centrifugation through an underlayered 10 ml 
cushion of 20% glycerol in Dulbecco's phosphate buffered saline (PBS-A) in 
a Beckman type 19 rotor at 19,000 rpm (50,000 x g) for 2 hr. Pelleted 
virus was suspended in PBS-A, pH 7 .4 , and sedimented to its equilibrium 
density (1.18 g/ml) (Montelaro et a l . , 1982) by centrifugation on 30 ml 
25 to 90% glycerol gradients in a Beckman SW-28 rotor at 28,000 rpm 
(130,000 x g) for 4 hr. The virus band was withdrawn with a Pasteur 
pipette, diluted with PBS-A to a total volume of 40 ml, and any remaining 
glycerol W8S removed by pelleting the virus by centrifugation in a 
Beckman SW-28 rotor at 28,000 rpm (130,000 x g) for 90 min. The final 
virus pellet was suspended in 10 mM sodium phosphate buffer, pH 7.2 , and
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stored at -80°C in 500 Ml aliquots.
Virus recovery was estimated as protein as determined by the Lowry 
assay (Lowry et a l . , 1951). Using the above procedures, about 10 mg of 
EIAV could be purified per week from 10 roller bottles of infected FEK 
cells yielding one liter of tissue culture fluid (Montelaro et a l . , 1982). 
EIAV Isolates
For biochemical and immunological comparisons, virus isolates were 
produced by serial passage of the prototype strain of EIAV In Shetland 
ponies (Orrego et a l . , 1982). The inoculum used in all serial passages 
between animals consisted of plasma, rsther than purified virus, in order 
to reproduce as closely 83 possible the conditions of natural Infection. 
Recovered virus Isolates were designated by passage, pony number, and 
isolate number. For example, isolate P I. M  represents virus recovered 
from plasma of a first passage animal, two weeks after inoculation when 
the animal became AGID test positive. Likewise, isolate P2.1-1 
represents virus Isolated from plasma during the first disease episode in 
a second passage animal. A total of 9 EIAV isolates were included in this 
study, as well as the prototype strain: four consecutive isolates from the 
third passage Animal *1 (P3.1-1 through P3-1—4) and five consecutive 
Isolates from the third passage Animal #2 (P3.2-1 through P3.2-5) 
(Figures 5 and 24).
Whenever possible, serum neutralization assays were performed 
according to the virus dilution-constant serum method (Montelaro et a l . , 
1984a), using serum taken from the same animal as the recovered EIAV
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prototype strain 
ElflU
I
P1.1-1
I
P2.1-1
AJ  P3.1-I -fr-P3.1-2 P3.I-3 -► P3.1-4
P3.2-1 -► P3.2-2 -► P3.2-3 -► P3.2-4 -*P3.2-5
Figure S. Inoculation scheme followed for the production of EIAV 
Isolates in experimentally infected Shetland ponies.
first
passage:
second
passage:
third
passages:
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isolates. Serum neutralizing activity was expressed as a logjQ
neutralizing index, calculated as the difference In logjQ titer of the virus
with or without test serum. A neutralizing index of 1.5 or greater was 
considered positive.
Production of Monoclonal Antibodies
All monoclonal antibodies used in this study were the generous gift of 
K. A. Hussain andK. L. Schnorr, Department of Veterinary Microbiology 
and Parasitology, Louisiana State University School of Veterinary 
Medicine, Baton Rouge, Louisiana. Briefly, BALB/c mice were immunized 
subcutaneously and intraperitoneally with 100 jig of lentil lectin-purified 
EIAV glycoproteins (see below) from the prototype strain of EIAV in 
Freund complete adjuvant. Mice were boosted on day 14 with antigen 
preparations in Freund incomplete adjuvant, and again on days 28 and 88 
with antigen in 10 mM sodium phosphate buffer, pH 7 .2 . Four days after 
the final injection, spleens were removed and minced, and the cells were 
fused with SP2/0 mouse myeloma cells, which lack hypoxanthlne-guanine 
phosphoribosyltransferase activity (Groth and Schneidegger, 1980). 
Hybridomas were selected on hypoxanthine-amlnopterin-thymidine (HAT) 
medium (Groth and Schneidegger, 1980), and cloned by at least three 
cycles of limiting dilution. Clones were screened for ElAV-speciflc 
antibody secretion in a solid-phase enzyme-linked immunosorbent assay 
technique using disrupted EIAV as antigen, as described previously (Shane 
et a l . , 1964). In order to insure monoclonality, hybridomas exhibiting
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anti-ElAV activity were cloned through two more cycles of limiting dilution 
before subsequent screening and amplification. Ascites fluids were 
produced by intraperitoneal injection of 1 x 10® to 5 x 10® hybridoma cells 
Into syngeneic mice which had been injected 10 days previously with 0.5 ml 
Pristane (Massey and Schochetman, 1981).
Radioactive Labeling of EIAV in Vivo
EIAV was labeled in vivo with [^H]-glucosamine using modifications of 
previously described procedures (Parekh et a l . , 1980). Infected FEK 
cells in 75 cm2 flasks were transferred to medium containing 1/I0th the 
normal amount of glucose for 24 hr. [^Hl-glucosamine was then added to 
the existing medium to a final concentration of 20 jiCi/ml. Medium was 
harvested after 48 hr and clarified of cellular debris by centrifugation in 
a Sorvall SS-34 rotor for 15 min at 12,000 rpm (13,000 x g ). Labeled 
virus was pelleted by centrifugation in a Beckman SW-28 rotor at 28,000 
rpm (130,000 x g) for 90 min. The virus pellet was suspended in PBS-A 
and stored at -20°C. The label-containing medium was then sterilized by 
filtration through a 0.45 jim sterile disposable filtration unit (Nalgene) 
and returned to the infected FEK monolayers. The medium was harvested 
a second time after an additional 48 hr, and labeled virus was isolated as 
above. The two [3H]-labeled EIAV harvests were combined, and virus was 
pelleted through an underlayered 1 ml cushion of 202 glycerol in PBS-A by 
centrifugation in a Beckman SW-50.1 rotor at 45,000 rpm (190,000 x g) 
for 1 hr. The virus pellet was suspended in 10 mM sodium phosphate 
buffer, pH 7.2 and stored at -80°C. Using these procedures, 2 .0  x 10® to
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4.5 x 106 (jpjm 0f [3H]-gIucosamine-labeled EIAV could be generated from 
5 flasks of infected FEK cells per labeling experiment.
Radioactive Labeling of EIAV Components in Vitro
a. I^5|]-iabeling of EIAV polypeptides using chloramine-T
Viral protein or glycoprotein components were radiolabeled with 
125l using the chloramine-T procedure (Hunter, 1978). The following 
solutions were prepared fresh in 100 mM sodium phosphate buffer, pH 7.4: 
chloramine-T, 4.0 mg/ml; sodium metabfsulfite, 2.5 mg/ml; and sodium 
iodide, 10.0 mg/ml. A 25 -  50 jig sample of protein was placed in a 10 x 
75 mm siliconized test tube, the total volume was brought to 200 j j l I  with 
100 mM sodium phosphate buffer, pH 7.4 , and 1 mCi [ ,25l]-sodium iodide 
(20 j il)  was added. Reaction wss initiated by addition of 25 jil 
chloramine-T. The reaction was allowed to proceed at 0°C for 3 min and 
then terminated by the addition of 100 jil sodium metabisulfite. To 
minimize noncovalent association of to proteins, 200 jil of nonlabeled 
sodium Iodide was added as carrier. Unreacted [ 125l]-sodium iodide was 
separated from radioiodinated protein using a 10-ml column of Sephadex 
G-25 prepared in a disposable pipette and eluted with 10 mM sodium 
phosphate buffer, pH 7 .2 .
The activity of [ 125l]-1abeted protein was expressed as acid 
precipitable counts. Duplicate 5 jil samples of the radioiodinated protein 
were mixed with 100 j j l I  1 mg/ml B5A and counted using a Packard 
Auto-gamma counter. Protein was precipitated by addition of 900 jxl cold 
10% TCA and incubation at 0°C for 30 min. Samples were centrifuged in an
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Eppendorf microfuge for 10 min, and the supernatant fluid was discarded 
to radioactive waste. The resultant protein pellets were counted to 
determine acid precipitable activity.
b. [^ l]- la b e lin g  of EIAV polypeptides in polyacrylamide gel slices 
In preparation for two-dimensional peptide mapping, certain EIAV 
polypeptides were radioiodinated in polyacrylamide gel slices after 
separation by SDS-PAGE (see below) according to modifications made to 
the chloramine-T procedure (Greenwood et a l . , 1963; Hunter, 1978). 
These modifications have been previously described (Elder et a l . , 1977b; 
Montelaro et a l . , 1984a; Salinovich et a l . , 1986). Protein bands 
visualized by coomassie blue staining corresponding to various 
polypeptides of EIAV were excised from the get, and each slice was placed 
in a perforated autoanalyzer cup and tightly capped. Gel slices were 
washed for 6-8 hr in 25% aqueous 2-propanol with vigorous stirring to 
remove coomassie blue. Gel slices were then transferred to 10% 
methanol, and washed with vigorous stirring for 16-18 hr to remove SDS, 
urea, and unpolymerized acrylamide. Gel slices were then transferred to 
separate 10 x 75 mm siliconized test tubes and dried completely under 
vacuum and mild heat. Before radioiodination, the following solutions 
were prepared fresh in 500 mM sodium phosphate buffer, pH 7.5: 
chloramine-T, 5 mg/ml; sodium metabisulfite, 1 mg/ml. Gel slices were 
rehydrated for 10 min in 50 Ml 500 mM sodium phosphate buffer, pH 7.5, 
and 1 mCi I 125|]-sodium Iodide (20 p i)  was added. Reaction was initiated 
by the addition of 10 jjlI chloramine-T, and allowed to proceed for 30 min
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at room temperature. Reaction was stopped by the addition of 1 ml sodium 
metabisulfite and incubation at room temperature for 15 min. The 
reaction buffer was then discarded to radioactive waste, and the gel 
slices were washed 10 times with 2 ml 10% methanol to remove unreacted 
on the gel surface. Gel slices were transferred to separate 
perforated autoanalyzer cups, tightly capped, and washed In 10% methanol 
for 48 to 96 hr to remove any remaining unreacted *25) _
Sodium Dodecvl Sulfate Polvacrvlamide Gel Electrophoresis and Analysts 
of Gels
The procedures used for sample preparation and sodium dodecyl 
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) in continuous 
sodium phosphate buffers in both slab and cylindrical gels hsve been 
previously described, as well as their analysis by staining, 
autoradiography, and fractionation (Montelaro and Bolognesi, 1978; 
Montelaro et a l . , 1982).
Gels used were 7.5% or 10% polyacrylamide containing 1 M urea, 0.1% 
SDS, 0.1% TEMED, and 100 mM sodium phosphate buffer, pH 7 .2 . Gels 
were polymerized by the addition of 5 ml 1% ammonium persulfate per 95 
ml of acrylamide monomer. Cylindrical gels were 0.6 cm in diameter and 
20 cm in length. Slab gels were 14 cm x 28 cm x 1.5 mm.
Electrophoresis buffer consisted of 100 mM sodium phosphate, pH 7.2, 
with 0.1% SDS and 10 mM 3-mercaptopropionate. All gels underwent 
electrophoresis for at lesst 1 hr at normal running conditions prior to 
application of samples in order to eliminate any peroxides formed during
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the polymerization reaction.
Aqueous samples of radiolabeled or unlabeled proteins were brought to 
a volume of 90 *il with 10 mM sodium phosphate, pH 7 .2 . Samples were 
then made 1% in both SDS and 2-mercaptoethanol (in a final volume of 100 
Ml), and heated for 3 min in a boiling water bath. Sucrose was added to 
give a final concentration of 20 to 30%, and 1 pi of 0.5% bromophenol blue 
in 0.02 N sodium hydroxide was added to each sample as a tracking dye. 
Samples were layered onto the gels followed by electrophoresis at 50 ma 
per slab gel or at 8 ma per cylindrical gel for a total of 18-22 hr. Buffer 
was circulated between the upper and lower chambers to prevent large pH 
differences from developing during electrophoresis.
Nonradfoacttve proteins were visualized In slab gels by first staining In 
0.25% coomassie brilliant blue in acetic acid: methanol: water 
(46:227:227, v /v /v) for 1 hr followed by complete destaining in acetic 
acid: methanol: water (3:10:27, v /v /v ).
Radioactive proteins were visualized in slab gels by either 
autoradiography or fluorography. Gels containing t '^^1]—labeled proteins 
were fixed in destaining solution for 1 hr, dried under vacuum and mild 
heat, and radiolabeled proteins were located by autoradiography using 
Kodak X-Omat XRP-5 film. Gels containing [^Hl-labeled proteins were 
fixed as above, then soaked for 1 hr in Autofluor before drying and 
autofluorography (Shealv et a l. . 1980).
Cylindrical gels containing radiolabeled proteins were analyzed by 
fractionation and counting. A highly-crosslinked plug of 40% acrylamide
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was cast on top of the gel after running, after which the gel was sliced in 
uniform increments into flat-bottom vials using a Gilson automatic gel 
fractionator (Gilson et a l., 1972). Gels containing M ^lH abeled  
proteins were fractionated Into distilled water, and fractions were 
counted directly in a Packard Auto-gamma counter. Gels containing 
I3H]-labeled proteins were fractionated into 50 mM ammonium 
bicarbonate, and proteins were allowed to elute from the gel particles 
overnight. Each fraction was then combined with 2 ml Tritosol (consisting 
of 5.46 g PPO and 0.54 g P0P0P dissolved in 60% xylenes, 25.7* Triton 
X-100, 10.6% absolute ethanol, and 3.7% ethylene glycol; v /v /v /v) and 
counted in a Beckman scintillation counter.
Discontinuous SD5-PAGE
For separation of EIAV polypeptides in preparation for two-dimensional 
peptide mapping, the discontinuous SDS-PAGE system developed by 
Laemmli (1970) was used. Slab gels of either 10% or 15% acrylamide 
(acrylamide: bisacrylamlde, 40:1) containing 0. t% SDS and 0.06% TEMED 
were prepared in 375 mM Tris-HCl, pH 8 .8 . Gels were polymerized by the 
addition of 5 ml 0.5% ammonium persulfate per 95 ml acrylamide 
monomer. A 4% acrylamide stacking gel containing 0.1% SDS in 120 mM 
Tris-HCl, pH 6.8 (3 to 4 cm in height) was overlayered onto the 
polymerized running gel. Samples of 100 Ml were prepared in a disruption 
buffer containing 625 mM Tris-HCl, 1% SDS, 10% glycerol, and 5% 
2-mercaptoethanol, pH 6 .8 , and heated in a boiling water bath for 3 min 
prior to loading. Slab gels were run at 25 ma for 18 to 22 hr.
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Electrophoresis buffer consisted of 25 mM Tris-HCl, 192 mM glycine, and 
0.1% SDS, pH 8 .3 . Buffer was circulated between the upper and lower 
chambers to prevent drastic changes in pH.
Proteins were visualized using procedures described above for 
separation by continuous SDS-PAGE.
Electrotransfer of Polvoeotides from SDS-PAGE to Nitrocellulose
Membranes
Proteins were transferred to nitrocellulose sheets after separation by 
SDS-PAGE according to previously described procedures (Burnette, 
t981) . The polyacrylamide gel containing proteins to be transferred was 
placed in direct contact with a nitrocellulose sheet which was previously 
soaked for 10 mln In a transfer buffer consisting of 20 mM Tris-HCl, pH 
8 .3 , and 150 mM glycine in 20% methanol. The gel and nitrocellulose 
sheet were then sandwiched between two pieces of Whatman 3mm 
chromatography paper and placed in a TE series Transfor apparatus 
(Hoefer Scientific Instruments) such that the polyacrylamide gel faced the 
cathode and the nitrocellulose sheet faced the anode. Electrotransfer of 
proteins to the nitrocellulose sheet was performed at 15°C for 16 to 18 hr 
at a constant current of 0.4 amp3. After transfer, the nitrocellulose 
sheet was directly used for tmmunoblotting techniques. The 
polyacrylamide gel was generally discarded, but in some cases was 
stained with Coomassie blue to detect any large molecular weight proteins 
which may not have transferred completely.
Jromunoblotting of P_olyoeptides on Nitrocellulose Membranes
41
After separation of EIAV polypeptides by SDS-PAGE and subsequent 
electrotransfer to nitrocellulose sheets, immunoreactive components 
were identified by Immunoblottlng with either a reference antiserum from 
a naturally infected horse, or with ascites fluids from monoclonal 
preparations described above. These immunoblottlng techniques have 
been described previously (Burnette, 1981; Salinovich et a l . , 1986). 
Except where otherwise indicated, all incubations were performed 8t room 
temperature.
a. Immunoblotting with horse antiserum
The nitrocellulose membrane to which EIAV polypeptides had been 
electrotransferred was initially incubated for 30 min at 37°C in 10 mM 
Tris-HCl, pH 7.4 with 0.9% sodium chloride (Tris/saline) containing 3% 
BSA, in order to block any non-specific binding of reactive antibody to the 
nitrocellulose surface. Test antiserum was diluted 1:100 with Tris/saline 
containing 3% BSA before incubation with the nitrocellulose membrane for 
90 min. The membrane was washed for 10 min in Tris/saline, followed by 
two 20 min washes in Tris/saline containing 0.05% NP-40, and finally 
washed for 10 min in Tris/saline. The nitrocellulose membrane was then 
incubated for 30 min In 50 ml Tris/saline containing 3% BSA and 4.3 x 107 
dpm t 1Z5I]-labeled protein A from Staphylococcus aureus. The 
nitrocellulose membrane was washed as described above, blotted dry on 
absorbent paper, and immunoreactive polypeptides were located by 
autoradiography using Kodak X-Qmat XRP film.
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b. Immunoblottlng with ascites fluids
Immunoblottlng with ascites fluids from monoclonal preparations 
was performed essentially as above, except that ascites fluids were 
diluted only t:SO in Tris/saline with 3% BSA prior to incubation with the 
nitrocellulose membrane. After incubation with the ascites fluid, the 
membrane was washed and incubated with goat anti-mouse immunoglobulin 
6 (IgG) for 90 min (700 mg IgG in 150 ml Tris/saline with 3% BSA). The 
membrane was again washed, and subsequent steps Including incubation 
with I l a b e l e d  protein A and autoradiography were performed as 
described above. This extra incubation with goat anti-mouse IgG was 
included since protein A binds very weakly, if at a ll, to certain mouse IgG 
subclasses (Kronvall, et a l., 1970; MacKenzfe, et a l.,  1978; Bruck et a l.,
1982).
Isolation of F3Hl-glucosamine-labeled EIAV glycoproteins
Between 1 x 10® to 1 x 10® dpm of purified EIAV labeled in vivo with 
[3H]-g1ucosam1ne was applied per 7.5% polyacrylamide cylindrical gel and 
run as described above. After running, the gels were cut into 2mm 
fractions, and proteins were eluted from the crushed gel overnight in 50 
mM ammonium bicarbonate, pH 8 .0 . Samples of 20 to 50 *il of each 
fraction were thoroughly mixed with 2 ml tritosol for scintillation 
counting. Fractions corresponding to a single peak of radioactivity were 
pooled, and crushed get particles were removed by centrifugation through 
Surety column filters in an clinical centrifuge at 1500 rpm for 5 min. The 
filtrate was lyophilized to dryness, then suspended in 1.0 ml distilled
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water. Samples of 20 to 40 jil of the final solutions were mixed with 2 ml 
tritosol for scintillation counting to determine final activity. Radiolabeled 
glycoproteins were stored at -80°C in 500 jil aliquots. In an average 
isolation, about 2.0 x 10s dpm of gp90 and 1.2 x 105 dpm of gp45 could be 
recovered from 1.0x10® dpm I3H]-glucosamine-labeled intact EIAV. 
Recovery of EIAV Glycoproteins or Glvcopeptides bv Lectin Affinity
Chromatography
a. Isolation of unlabeled EIAV glycoproteins
The EIAV glycoproteins gp90 and gp45 were recovered from whole 
virus preparations by affinity chromatography on a column of lentil lectin 
(from Lens culinaris) covalently bound to Sepharose 48, using procedures 
described previously (Montelaro et a l . , 1983). The lentil lectin column 
(0 .8 x 8  cm) typically consisted of a 4 ml total bed volume, and was 
equilibrated with 10 to 15 ml 20 mM Tris-HCl, 100 mM NaCl, pH 8.0 (Buffer 
A ), containing 0.1% DOC. Lipid was removed from 5 to 15 mg purified EIAV 
by precipitation of viral proteins with 10 volumes of cold acetone and 
incubation at 0°C for 30 min. Precipitated proteins were collected by 
centrifugation in a Sorvall SS-34 rotor at 10,000 rpm (10,000 x g) for 10 
min at 4°C. The protein pellet was suspended in enough Buffer A 
containing 0.5% DOC to bring the final protein concentration to 1.0 mg/ml 
and frozen overnight. The rapidly thawed virus sample was then diluted 
with enough Buffer A containing 0.5% DOC to bring the final protein 
concentration to 0 .5  mg.ml, and protein aggregates were completely 
disrupted by 2 cycles of Incubation at 37°C for 1.5 min followed by
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sonication for 20 sec. The sample was then applied to the prepared lentil 
lectin column at a flow rate of 9 to 10 m l/hr, and protein elution was 
monitored by absorbance at 280 nm. The column was washed with 10 to 15 
ml Buffer A containing 0.1% DOC, or until a steady baseline was regained. 
Glycoproteins binding to the column were eluted with 10 to 15 ml Buffer A 
containing 0.1% DOC and 200 mM or-methylglucoside. Fractions containing 
unbound (non-glycosylated) and bound (glycosylated) proteins, 
respectively, were pooled and dialyzed for 36 hr against 100 mM 
ammonium bicarbonate, pH 8.0  and 12 hr against 50 mM ammonium 
bicarbonate, pH 8 .0 . The dialyzed pools were lyophilized to dryness, 
suspended in 10 mM sodium phosphate buffer, pH 7 .2 , and stored at 
“80°C. Protein was quantitated in each pool by the Lowry assay (Lowry et 
al. 1951). Generally, 12 mg of whole EIAV treated in this manner yielded 
5 to 6 mg protein in the lectin nonbinding pool and 0.5 to 0.7 mg protein in 
the lectin binding pool.
b. isolation of radiolabeled glycopeptldes
Procedures described previously for isolation of the EIAV 
glycoproteins gp90 and gp45 were adapted to accommodate the minute 
quantities of material present in radiolabeled samples (Montelaro et a l.,
1983). Columns of lentil lectin (from Lens cullnarls) or concanavalin A 
(from Canavalia ensiformis) covalently bound to Sepharose 4B (total bed 
volume 1 ml) were poured in 1 ml tuberculin syringes plugged with glass 
wool. Proteolytic digests of either [^Hl-labeled or [*^^1]—labeled 
glycoproteins were lyophilized to dryness, then suspended in 200 prt
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Buffer A with 0. \ % DOC. Samples were applied to the columns and allowed 
to bind for 5 min with flow stopped. After flow was resumed, 0.5 ml or 
1.0 ml fractions were collected, and nonbinding components were washed 
from the columns with 10 ml Buffer B with 0.1% DOC. Components binding 
to the columns were eluted with 10 ml Buffer B containing 0 . \% DOC and 200 
mM oc-methyl glucoside. Peaks of radioactivity were located either by 
counting fractions directly in a Packard Auto-gamma counter ( ^ 5 | ) ,  or 
30 pi of each fraction were mixed with 2 ml tritosol for scintillation 
counting (^H). Fractions corresponding to lectin binding (glycosylated) 
peptides were pooled and placed in Spectrapore 3 dialysis tubing, which 
had been previously boiled for 15 min in 10 mM EDTA, pH 8.0 to decrease 
the pore size such that components of molecular weight greater than 700 
would be retained. Samples were dialyzed for 36 hr against 100 mM 
ammonium bicarbonate, then 12 hr against 50 mM ammonium bicarbonate. 
Dialyzed samples were lyophilized to dryness and stored at -20°C. 
Isolation of EIAV Internal Polypeptides bvHPLC Reverse Phase
Chromatography
The internal EIAV protein p9 was purified for subsequent 
two-dimensional peptide mapping by reverse phase high performance 
liquid chromatography (HPLC) according to modifications of previously 
described procedures (Henderson et a l . , 1984; J. Ball» unpublished 
results). The solvent delivery system used was a fully programmable 
Varian 5000 HPLC with two solvent channels. Samples consisting of 1200 to 
1400 pg lentil lectin nonbinding (nonglycosylated) proteins (see above) in
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600 Ml 3.5 M guanidine hydrochloride, pH 3.1 were injected onto a Waters 
MBondapak phenyl column (30 cm x 3.9 mm) equilibrated at 37°C in 0. IX 
trifluoroacetic acid (TFA) in water (Solvent A) at a flow rate of 1 ml/min. 
After sample Injection, the column was flushed for 1 m1n with Solvent A, 
followed by elution of component polypeptides from the column with 
increasing amounts of 0.1% TFA in acetonitrile (Solvent B) according to 
the following program: (All segments consist of linear gradients.)
0 to 25% Solvent B in 25 min;
25 to 41% Solvent B in 32 min;
41 to 45% Solvent B in 20 mini
45 to 55% Solvent B in 20 min;
55 to 60% Solvent B in 5 min.
Elution of polypeptides was monitored by absorbance at 280 nm, and 1 ml 
fractions were collected. Fractions corresponding to protein peaks were 
pooled and lyophilized to dryness, then suspended in 50 to 90 Ml 10 mM 
sodium phosphate buffer, pH 7.2 for subsequent SDS-PAGE analysis. 
Protein bands stained with coomassie blue corresponding to the EIAV 
polypeptide p9 were excised from the gels for two-dimensional peptide 
mapping.
Enzvmatlc Digestion of Radiolabeled Polypeptides
a. Trypsin digestion of [ ' 25J]-labeled polypeptides
Samples containing 40 x 10  ^to 70 x 105 dpm were lyophilized to 
dryness, suspended in 90 Ml 30 mM ammonium bicarbonate buffer, pH 8 .0 , 
and 10 jil DPCC-treated trypsin (1 mg/ml) was added. The reaction
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mixture was incubated at 37°C for 24 hr. Reaction was stopped by addition 
of 6 Mi soybean trypsin inhibitor (1 mg/mi) and incubation at 37°C for 30 
min. Digests were lyophilized to dryness and stored at -20°C.
b. Trypsin digestion of radiolabeled polypeptides In polyacrylamide 
gel slices
Gel slices containing ['25|]-iabeled polypeptides to be mapped in 
two dimensions were placed in separate 10 x 75 mm siliconized test tubes 
and dried completely under vacuum snd mild heat. Slices were 
rehydrated for 10 min in 30 jjtl DPCC-treated trypsin, followed by the 
addition of 500 Ml 50 mM ammonium bicarbonate buffer, pH 8 .0 . Mixtures 
were incubated at 37°C for 24 hr, and tryptic peptides were passively 
eluted into the reaction buffer. The peptide-containing buffer was 
carefully pipetted from the gel slice into an Eppendorf tube, lyophilized to 
dryness, and suspended in 30 Ml acetic acid: formic acid: water (15:5:80; 
v /v /v) (electrophoresis solvent) for subsequent two-dimensional peptide 
mapping.
c. Neuraminidase digestion of radiolabeled glycopeptides 
Procedures described previously (Van Eldik et a l . , 1978; Montelaro
et a l. ,  1984b) for removal of terminal sialic acid residues from 
glycopeptides were modified as detailed below. Samples consisting of 5.5 
x 104 to 1.0 x 105 dpm [3HJ—labeled glycopeptides or 1.5 x 106 to 7.0 x 
106 dpm [ labeled glycopeptides were diluted to 100 Ml with 50 mM 
ammonium acetate, pH 5 .0 , and 5 Ml (25 mUnits) neuraminidase were 
added. The reaction mixtures were incubated at 37°C for 6-8  hr, followed
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by a second addition of 5 jjl neuraminidase. Reaction mixtures were 
incubated an additional 16-18 hr at 37°C, then reaction was stopped by 
heating the digests in a boiling water bath for 3 min. Digests were 
lyophilized to dryness and stored at -20°C.
Two-Dimensional Peptide and GIvcop^Mide Mapping of EIAV Polypeptides 
Two-dimensional peptide and glycopeptide analysis on cellulose-coated 
thin layer plates was performed according to previously published 
procedures (Elder et a l . , 1977b; Montelaro et a l . , t984a; Salinovich et 
a l.,  1986; Salinovich and Montelaro, 1986).
a. Two-dimensional peptide mapping
Samples to be analyzed consisted of 1.5 x 10® to 7.0 x 10® dpm 
[ 125 l]-labeled tryptic digests of the given EIAV component in 1 to 5 jil 
acetic acid: formic acid: water (15:5:80; v /v /v ) (electrophoresis 
solvent). The sample was carefully applied in 1/4 jil portions to the 
bottom left corner of a cellulose-coated thin layer plate ( 0.1 mm thick on 
20 x 20 cm plastic support) at a point 2.5 cm from each edge. Tracking 
dye consisting of 2% orange G and 1% acid fuschin in electrophoresis 
solvent ( 1/2 mD was applied to the upper right corner of the same thin 
layer plate, 2.5 cm from the right edge and 1.25 cm from the top edge. 
The entire plate was then dampened with electrophoresis solvent, and 
placed in a Pharmacia FBE 3000 flat-bed electrophoresis unit such that the 
sample was nearest the anode and the tracking dye was nearest the 
cathode. Electrophoresis was performed at 5°C with a constant potential 
of 1000 volts, until the tracking dye had migrated 10.5 cm from the right
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edge of the plate. The thin layer plate was air dried, followed by 
ascending chromatography in a solvent consisting of 1-butanol: pyridine: 
acetic acid: water (6.5:5:i:4; v /v /v /v ) for 8 hr in a direction 
perpendicular to the direction of electrophoresis. The plate was again air 
dried, and radiolabeled peptides were located by autoradiography using 
Kodak X-Omat XRP film . Time of autoradiography varied from 2 hr to 5 
days, depending on the polypeptide analyzed,
b. Two-dimensional glycopeptide mapping
Two-dimensional glycopeptide mapping was performed essentially 
as described above, with the following modifications. Samples consisted 
of lectin-binding glycosylated peptides (see above) isolated after 
radfolabeltng and trypsin digestion of the component to be analyzed. 
Activity of the samples was considerably lower, containing only 1.5 x 105 
to 7.0 x 10* dpm labeled glycopeptides or 2.0 x 10  ^to 5.0 x 10^
dpm I^H]—labeled glycopeptides in 5 pi electrophoresis solvent. 
Electrophoresis was performed under the same conditions as above, but 
the tracking dye was allowed to migrate 15 cm from the right edge of the 
plate. Chromatography was performed in a modified solvent consisting of 
1-butanol: pyridine: acetic acid: water (5:5:1:7.5; v /v /v /v ) for 10 hr. 
(I25|]_iabeled glycopeptides were located by autoradiography as above, 
but thin layer plates containing t3H3—labeled glycopeptides had to be 
dipped in 0.5% PPO in 2-methylnaphthalene in order to perform 
autofluorography. Time of autofluorography was generally two to three 
weeks.
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Computer Analysis of EIAY-Amino Acid Sequences
All computer analyses were performed using programs offered by 
Intelligenetics, Inc. through its Bionet system, with an IBM-PC serving as 
a local terminal. Hydropathic analysis of the predicted EIAV envelope 
amino acid sequence derived from the previously reported prototype DNA 
proviral sequence (Rushlow et a l . , 1986) was performed according to the 
algorithms developed by Kyte and Doolittle (1982). Prediction of 
secondary structure from amino acid sequences was performed according 
to the algorithms and criteria developed by Chou and Fasman (1974,
1978). All parameters assigned to amino acids for these calculations are 
given in Appendix III.
CHAPTER 3 
RESULTS
I. COMPARATIVE ANALYSIS OF FOUR CONSECUTIVE EIAV ISOLATES
The antigenic properties of four EIAV isolates were compared in 
neutralization assays, as well as In Immunoblot analyses using either 
polyclonal or monoclonal antisera. Structural studies of these same 
isolates included analysis of the component polypeptides by SDS-PAGE and 
two-dimensional mapping of radioiodinated tryptic peptides. Previous 
preliminary studies involving structural analysis of EIAV isolates 
(Montelaro et a l . , 1984a) included only the major surface glycoprotein 
gp90, and the internal non-glycosylated polypeptides p26, p i5, and p9.
In the present study, the second surface antigen gp45 was also subjected 
to two-dimensional peptide analysis. In addition, the two-dimensional 
mapping procedure was modified such that glycosylated peptides of both 
gp90 and gp45 could be analyzed for the first time.
EIAV Isolates
EIAV Isolates for this study were recovered from experimentally 
infected Shetland ponies in which the cell-adapted prototype strain of the 
virus had been serially passaged (Orrego et a l . , 1982). Figure 5 shows 
the inoculation scheme used, as well as virus isolate designation and 
replication path. The four Isolates used in this study (P 3 .1-1 through
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Figure 6 . Plot of daily rectal temperature of a third passage animal, 
showing disease episodes and points at which virus isolates were 
recovered.
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P3.1-4) were recovered during the first four sequential disease episodes 
in one of two third passage animals. Figure 6 shows a plot of daily rectal 
temperature of this animal, as well as the points at which the virus 
isolates were recovered. No virus could be recovered from plasma taken 
between episodes, which is in agreement with previous findings COrrego et 
a l.,  1982). For subsequent biochemical studies, the predominant virus 
present in the plasma during each episode was isolated by endpoint 
dilution, then propagated in fetal equine kidney cells and purified as 
described in Materials and Methods.
Antigenic Studies
a) Serum neutralization
Neutralization assays were Initially performed by the virus 
dilution-constant serum method, using serum from the same animal 
(Salinovich et a l . , 1986). The results of these assays are shown in Table 
III. In general, serum recovered between disease episodes was capable 
of neutralizing any previous EIAV Isolates, but could not neutralize any 
subsequent isolates. Serum taken 31 days postinoculation showed 
equivalent reactivity toward both isolates P3.1-1 and P3.1-3, which may 
be an artifact of the low neutalizing ability of this serum. The failure of 
serum taken 158 days posttnoculation to neutralize isolate P 3 .1-4 may be 
due to a combination of factors. The animal may not have had sufficient 
time to produce neutralizing antibody only 21 days after the last disease 
episode. Also, it has been previously demonstrated that EIAV infects 
monocytes and macrophages, and may alter the infected animal's ability
54
Table I I I .  Serum neutralization indeces of sera collected at different 
times after inoculation.
Neutralization indexb of serum collected , 
on the following day postinoculation:
Virus strain VIDa 31 125 158
P3.1-1 13 1.5 3.0 3.0
P3.1-2 41 0.5 3.0 3.0
P 3.1-3 99 1.5 2 .0 1.0
P3.1-4 137 1.0 1.0 1.0
8 Days postinoculation when plasma was collected.
b Log jo serum neutralization index (positive if 2.1 .5 ) as described in 
Materials and Methods.
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to mount an effective immune response (McGuire et a l . , 1971; Ushimi et 
a l. ,  1972).
The results of these neutralization assays indicate that distinct 
antigenic variants of EIAV are associated with each disease episode 1nthe 
sequential series, which confirms and extends previous reports of 
antigenic variation in EIAV (Kono et a l . , 1973; Montelaro et a l . , 1984a; 
Salinovich et a l., 1986). In addition, the data demonstrate that the time 
required for EIAV to vary Its antigenic reactivity such that It can escape 
host immune defenses can be as short as 28 days (the time between the 
recovery of isolates P3.1-1 and P3.1-2). Thus, the time frame required 
for antigenic variation in EIAV is considerably shorter than that reported 
for visna virus, which requires 1 to 2 years for the appearance of 
antigenically distinct virus strains in the persistently infected animal 
(Scott e ta l . ,  1979; Clements et 8l . , 1980).
b) immunoblot analysis
As shown In the neutralization studies, these four Isolates are 
recognized by the host to be antigenically distinct, thus providing a unique 
system with which to study antigenic variation in a lentivirus. Initially, 
immunoblot analysis of the EIAV isolates with a polyclonal equine 
reference antiserum was performed to Identify EIAV polypeptides 
recognized by the host’s immune response during natural infection. Whole 
virus preparations of each of the four isolates, as well as the prototype 
strain, were disrupted and the component polypeptides were separated by 
SDS-PAGE in 10% gels. A typical gel pattern obtained after coomassle
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staining is shown in Figure 7A. Since gp90 and gp45 together comprise 
only 10% of the viral protein (Parekh e ta l . ,  1980), they cannot be 
easilylocated in this protein pattern. The internal proteins p26, p15, 
pi 1, and p9, which comprise almost 85% of EIAV by weight, can all be 
easily identified in the isolates analyzed.
Once the polypeptide components of each isolate were separated by 
SDS-PAGE, they were transferred to a nitrocellulose membrane and 
Immunoblotted with a broadly-reactlve reference antiserum obtained from 
a naturally infected horse (designated Lady). The resulting immunoblot 
of the five Isolates is shown in Figure 7B. This broadly-reactive 
antiserum predominantly recognized both gp90 and gp45 from the 
prototype strain of the virus (lane 1) ,  even though they are present in 
relatively low quantities (about 4 ug and 2 Mg* respectively). In 
contrast, this antiserum only weakly recognized p26, even though it is 
present in much higher quantities than the two glycoproteins (about 27 
jig ). This antiserum recognized both glycoprotein components, as well as 
the p26 component, from all of the EIAV isolates analyzed. Some 
variation, however, was observed in the degree of reactivity of the 
reference antiserum to the glycoproteins of the different isolates. The 
serum displayed a very poor reactivity to the gp45 component of isolate 
P3.1-3, whereas it reacted strongly with gp45 from the remaining isolates 
(Salinovich et a l.,  1986). Also, variation in electrophoretic mobility of 
both the gp90 and gp45 components from all five isolates was evident,
Figure 7 . Analysis of polypeptides from EIAV isolates, (A ) SDS-PAGE 
separation of virion polypeptides, visualized by coomassle staining. (8 ) 
Immunoblot analysis of a similar SDS-PAGE separation with a broadly 
reactive polyclonal antiserum. Equal amounts (50jig) of each virus 
isolate are present in each lane. Prototype EIAV was included as a 
reference.
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suggesting that some structural changes may have occurred in these two 
glycoproteins.
To further identify contributions of gp90 and gp45 to the antigenic 
variation demonstrated in the neutralization studies, immunoblot analyses 
similar to that described above were performed with the four third 
passage isolates using a panel of monoclonal antibodies raised against 
either gp90 or gp45 recovered from the prototype strain of EIAV. As 
shown in Table IV, all five monoclonal antibodies specific for gp90 reacted 
strongly with this glycoprotein from the prototype virus. A similar 
pattern of reactivity was seen for gp90 from isolate P3.1-1.
Interestingly, isolates P3.1-1 and P 3 .1-3, which exhibited equivalent 
neutralization properties, differed In the reactivity of only one 
monoclonal antibody, suggesting that they indeed express very similar 
antigenic properties. All four isolates could be distinguished 
antigenically on the basis of their reactivity with this panel of 
gp90-specific monoclonal antibodies, which parallels and confirms the 
findings of the neutralization assays. This data shows for the first time 
the occurrance of antigenic variation at distinct epitopes of gp90 from 
EIAV isolates recovered only weeks apart from a single animal.
In contrast, the three monoclonal antibodies specific for gp45 
recognized this glycoprotein from all four EIAV isolates as well as the 
prototype strain. Since no competitive binding assays have been 
performed with these monoclonals, the possibility that all three recognize 
the same epitope cannot be excluded. Therefore, ft appears from the
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Table IV. Reactivity patterns of eight monoclonal antibodies specific for 
either gp90 or gp45. Monoclonal antibodies were generated against the 
glycoproteins of prototype EIAV, and were then used to screen five EIAV 
antigenic variants in immunoblot analyses. A (+) denotes positive 
reactivity, a ( - )  denotes no reactivity, and a (+ /- )  denotes very weak 
positive reactivity.
MAb reactivity prototype P3.1-1 P 3 .1-2 P 3.1-3 P3.1-4
1 gp90 + + + /“ + —
2 gpQO + + + / - + —
86 gp90 + + + + +
95 gp90 + + + + + / -
115 gp90 + + + — +
30 gp45 + + + + +
101a gp45 + + + + +
105 gp45 + + + + +
aSubtyped as lgG2b* remaining monoclonal antibodies are subtyped as 
IgGl-
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results obtained with this limited panel of monoclonal antibodies that while 
both gp90 and gp45 may be involved in antigenic variation in EIAV, gp90 
contributes more to this variation than does gp45.
Structural Analysis '
a) SDS-PAGE
The variation in electrophoretic mobility observed for the gp90 and 
gp45 components of the four EIAV isolates in the immunoblottlng analyses 
suggests that structural variation may be occurring in these 
glycoproteins. Structural variation has been previously demonstrated by 
two-dimensional peptide analysis of the gp90 component from EIAV 
Isolates recovered months apart from different experimentally infected 
animals (Montelaro et a l., 1984a). To determine if such structural 
variation could be detected in the glycoprotein components of EIAV 
isolates recovered only weeks apart from a single animal, similar 
analyses were conducted with each of the four isolates presently under 
study. In preliminary experiments, each isolate was purified after 
propagation in tissue culture, followed by separation of the viral 
polypeptides by lentil lectin affinity chromatography. The components of 
the lectin binding (glycosylated) and non-binding (non-glycosylated) 
protein pools were then separated by SDS-PAGE in 10% gels and visualized 
by coomassie staining.
As seen in Figure 8A, the lectin non-binding pool of each isolate 
contained the internal viral polypeptides p26, p i5, pi 1, and p9. All four
Figure 8 . SDS-PAGE analysis of lentil lectin non-binding (A ) and binding 
(B) polypeptide pools of four EIAV isolates. Prototype EIAV was included 
as a reference.
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internal polypeptides exhibited essentially identical electrophoretic 
mobilities, regardless of the isolate from which they were derived. The 
lectin binding pools from each isolate, shown in panel B, contained the 
viral glycoproteins gp90 and gp45, as well as several contaminating 
cellular and/or serum glycoproteins. As in the immunoblot analyses, the 
electrophoretic mobility of both the gpQO and gp45 components varied 
between isolates, whereas the mobilities of the internal viral polypeptides 
remained constant. In addition, the mobilities of the bands tentatively 
identified as contaminating glycoproteins also remained constant. This 
observed variation in mobility for both EIAV glycoproteins was highly 
reproducible in different viru3 preparations, and did not change even 
after prolonged passage in tissue culture. These results closely parallel 
the previous studies with other EIAV variants (Montelaro et a l . , 1984a), 
where the gp90 and gp45 components also exhibited variations in their 
electrophoretic mobilities.
b) Two dimensional peptide analysts — gp90 and gp45
Since it has not yet been possible to purify significant quantities of 
gp90, structural analysis of this glycoprotein was performed by two 
dimensional peptide mapping using procedures originally developed by 
Elder et al. (1977b), and modified as described previously (Montelaro et 
a l . , 1984a; Salinovich et a l . , 1986). These procedures include the 
radioiodination and trypsin digestion of polypeptides within a 
polyacrylamide gel matrix, such that single proteins which cannot be 
otherwise purified can be excised from polyacrylamide gels after
63
electrophoretic separation and analyzed effectively. As is apparent in 
Figure 8B, it is virtually impossible to separate the gp90 component of 
several of the isolates (P 3 .1-1, P3.1-2, and P3.1-3) from a 
closelymigrating cellular contaminant with the continuous sodium 
phosphate gel system used. To obtain the necessary separation, the 
components of the lectin binding pool from each isolate were separated 
using the discontinuous gel system developed by Laemmli (1970). The 
resultant analysis of these five EIAV Isolates in a 10* gel Is shown In 
Figure 9. Sufficient separation was achieved between gp90 and the higher 
molecular weight contaminant, even in isolates where the migration of 
gp90 is slower than that in prototype virus.
Once sufficient separation was achieved, protein bands corresponding 
to the gp90 component of each isolate were excised from the gel, 
radioiodinated and trypsin digested as described (Montelaro et a l . , 1984a; 
Salinovich et a l.,  1986), and the subsequent radiolabeled digests were 
subjected to two dimensional peptide analysis. To facilitate direct 
comparison of maps from the different isolates, the gp90 component from 
the four third-passage isolates were mapped at the same time under 
identical conditions. The gp90 component from prototype EIAV was 
Included in each analysis as a control. To obtain a systematic 
comparison, each isolate is compared to its immediate predecessor, such 
that P3.1-2 is compared to P3.1-1, P3.1-3 is compared to P3.1-2, and 
P3.1-4 is compared to P3.1-3.
Figure 9 . SDS-PAGE analysis of the lentil lectin binding polypeptide 
pools of four EIAV isolates, using a discontinuous electrophoresis 
system. Prototype EIAV was included as a reference.
65
As seen in Figure 10, there are both peptide additions and deletions 
occurring in the gp90 peptide patterns in each pair of isolates examined.
In addition, no two isolates exhibited identical gp90 peptide patterns. 
Three to five maps of each virus isolate were studied, and the denoted 
peptide differences were consistently observed in all maps. Also, the 
maps obtained were completely reproducible, even after passage of the 
virus strains in tissue culture for up to six months. These results 
demonstrate that structural variation can be seen in gp90 from EIAV 
isolates recovered only weeks apart from the same animal, and that these 
structural changes occur concurrently with antigenic changes in this 
surface glycoprotein.
Since the gp45 component also exhibited electrophoretic mobility 
changes between virus isolates, this glycoprotein was included in the 
two-dimensional peptide analysis. However, previous attempts to obtain 
peptide patterns of gp45 from EIAV variants using the above procedures 
failed due to high background, possibly due to contamination from cellular 
glycoproteins migrating with gp45 in sodium phosphate gels. Such 
contamination can clearly be seen in Figure 9, where three bands are 
present in the 41,000 to 45,000 da region of this 10% Laemmli gel, instead 
of the one broad band seen in the corresponding regfon of the 10% sodium 
phosphate gel shown in Figure 8B. To identify which of the three bands 
evident in the Laemmli gel is actually gp45, separate samples of 
^H-glucosamine-labeled gp45 and lentil lectin binding components from 
prototype EIAV were separated by electrophoresis in adjacent wells of a
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Figure 10- Two-dimensional tryptic peptide maps of the gp90 component 
from four EIAV isolates. Arrows and open circles indicate peptide 
additions and deletions, respectively, observed when each isolate is 
compared to its immediate predecessor. Electrophoresis was performed 
in the horizontal direction (left to right), followed by ascending 
chromatography in the vertical direction.
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102 Laemmli gel. After electrophoretic separation, protein bands were 
visualized by appropriate methods, and the two profiles were compared 
such that the band corresponding to gp45 could be located.
As seen in Figure 11 (lane 3 ), 3H-labe1ed gp45 migrates in the gel in a 
rather wide band, which coincides with the lower two bands Cb‘ and "c") 
of the triplet seen in this region of the coomassie stained gel (lane 2 ). 
Location of gp45 by immunoblot analysis yielded identical results. 
Therefore, although the uppermost band of the three Ca’ , lane 2) could 
be tentatively eliminated, both lower bands were possibly gp45. Thus, 
the two lower bands were excised from the gel separately, and each was 
subjected to two-dimensional peptide mapping.
The resultant peptide patterns for these two protein bands, shown In 
Figure 12, are surprisingly similar, suggesting that the two bands 
represent different forms of gp45. In contrast, the peptide pattern 
obtained for band "a" was completely distinct from those of bands "b* and 
"c“ (data not shown). There are only six peptides present In the map of 
the upper band which are not present in the map of the lower band 
(designated by open circles), and two peptides present in the lower band 
which are not in the upper band (designated by arrows). Since it appears 
that both bands are present In 3H-glucosamine labeled gp45, It Is highly 
unlikely that one band represents a non-glycosylated form of this 
glycoprotein. Also, the peptide map of the larger band possesses several 
additional peptides not present in the map of the lower band, suggesting 
that the lower band may be derived from the upper band by proteolytic
3 0 K -
Figure 11. Location of gp45 In a 10% discontinuous SDS-PAGE analysis. 
Lane 1 - -  standard molecular weight markers; Lane 2 — coomassie 
stained gel analysis of the lentil lectin binding polypeptide pool from 
prototype EIAV; Lane 3 —  I^H]-glucosamine labeled gp45 from prototype 
EIAV.
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9P45$!
Figure 12. Two-dimensional tryptic peptide maps of the two possible 
gp45 components. Arrows and open circles represent peptide additions 
and deletions, respectively, observed when the lower band map is 
compared with the upper band map.
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cleavage. Such proteolytic cleavage of the transmembrane env gene 
product has been documented in Rauscher murine leukemia virus, in which 
p!5E is cleaved to form plZE (Karshin, et a l. ,  1977; Jamjoon, e ta l . ,  
1977).
Once the protein bands corresponding to the gp45 component had been 
identified, two-dimensional peptide patterns for this glycoprotein from 
each of the four third passage isolates were generated, and are shown in 
Figure 13. Both gp45 bands for each Isolate were mapped together, such 
that the maximum amount of variation in this component could be 
detected. The large amount of background radioactivity which had been 
seen in previous attempts to map gp45 was effectively eliminated, 
allowing this glycoprotein to be analyzed for the first time. As was seen 
for the gp90 component, there are both peptide additions and deletions 
occurring in gp45 between each isolate and its immediate predecessor. 
Also, no two isolates exhibited identical gp45 peptide patterns. As with 
the gp90 maps, three to five maps of gp45 from each Isolate were 
analyzed, and the peptide patterns obtained were highly reproducible, 
even after prolonged passage of these isolates in tissue culture. These 
results demonstrate for the first time that structural variation occurs in 
both surface glycoproteins of EIAV during replication 1n a single animal.
d) Glycopeptide analysis — gp90 and gp45
The two dimensionat mapping technique used above to analyze gp90 
and gp45 does not resolve peptides containing carbohydrate (Montelaro et 
a l . , 1984a). Glycosylated peptides migrate In the first dimension
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P3.1-1
P3.1-3
P3.1-2
P3.1-4
Figure 13. Two-dimensional tryptic peptide maps of the gp45 component 
from four EIAV isolates. Arrows and open circles indicate peptide 
additions and deletions, respectively, observed when each isolate is 
compared to its immediate predecessor.
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electrophoresis, but do not migrate in the second dimension 
chromatography, thus forming a characteristic pattern of unresolved 
peptides extending from the sample origin across the bottom of the peptide 
pattern. It has previously been shown that at least 10% to 15% of the 
natural host immune response to gp90 is directed toward the carbohydrate 
moiety of the molecule (Montelaro et a l . , 1984b), Also changes in the 
glycosylation pattern of other viral surface glycoproteins can drastically 
alter their antigenicity (Alexander and Elder, 1984; Kawoaka et a l.,
1984). Therefore, it is important to be able to analyze glycosylation 
patterns in the EIAV gp90 and gp45 components.
Conventional methods for the characterization of carbohydrates, which 
require relatively large amounts of purified material, cannot be 
performed with either EIAV glycoprotein, since neither has yet been 
purified in sufficient quantities. In addition, analysis of glycoprotein 
oligosaccharides employing gel filtration procedures, although useful for 
some comparisons, are of relatively low resolution and provide no 
information about sites of glycosylation (Hunt and Wright, 1981, 1983). 
Therefore, we sought to modify the two-dimensional peptide mapping 
procedure such that glycosylated peptides could be resolved, and 
glycopeptide structural analysis could be performed with gp90 and gp45 
from the panel of EIAV isolates.
The two well characterized glycoproteins, fetuin andaj-acid 
glycoprotein, were used for the development of the modified mapping 
technique. Each is readily available commercially in large quantities,
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and with rather high purity. The apacid glycoprotein was chosen since it
is a relatively small glycoprotein (MW = 21,000) which contains five 
N-linked carbohydrate side chains whose structure and position of 
attachment in the amino acid sequence are known (Figure 14A) (Schmid et 
a l., 1973; Schwarz man et a l . , 1978). Fetuln was Included because 1t 
contains three O-linked as well as three N-linked carbohydrate side 
chains, the structures of which have been previously determined (Figure 
MB) (Spiro and Bhoyroo, 1974; Nilsson et a l . , 1979).
The two glycoproteins were radiolodinated by the chloramlne-T' 
method, followed by 24 hr trypsin digestion. The resultant digests of both 
standard glycoproteins were analyzed by conventional two-dimensional 
peptide mapping, the results of which are shown in Figure 15A. The 
characterisitic unresolved pattern is clearly evident at the bottom of the 
maps for both glycoproteins. Glycosylated peptides were then separated 
from the digests by affinity chromatography on columns of either
conconavalin A (for fetuin) or lentil lectin (for apacid glycoprotein) 
bound to Sepharose 4B, and analyzed by the same peptide mapping 
technique (Figure 15B). As demonstrated previously for EIAV gp90 
(Montelaro et a l . , 1984a), the glycosylated peptides of these two 
standard glycoproteins failed to migrate in the second dimension 
chromatography.
The first approach taken in the development of an effective 
glycopeptide solvent was to decrease the amount of 1-butanof and
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Figure 14. Structures of oligosaccharides present on «i~ac1d 
glycoprotein (A) and fetuin (B).
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fetuin oc,-acicJ
• A #
• I t
B
feluin a.-acid
Figure 15. Two-dimensional tryptic peptide maps of the standard 
glycoproteins. (A) Peptide patterns obtained for digests of fetuin and 
apacid glycoprotein. (B) Peptide patterns obtained for the lectin binding
(glycosylated) peptide pools of digests of fetuin and apacid glycoprotein.
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increase the amount of water in the peptide chromatography solvent, such 
that migration of the more hydrophilic glycopetides would be favored. It 
was found that changing the ratios of the components from 6.5:5M:4 to 
5:5M:7.5 ( 1-butanol: pyridine: acetic add: water; v /v /v /v ) produced a
solvent in which the glycosylated peptides of both fetuin and apacid
glycoprotein migrated during chromatography.
Once this suitable solvent was developed, full two dimensional 
patterns of the glycosylated peptides of the two standard proteins were 
produced. Since gp90 is at least twice the molecular weight of the 
standard protein fetuin, this glycoprotein from the EIAV isolate P3.1-1 
was also included to determine if size might be a prohibitive factor in this 
analysis. Electrophoresis in the first dimension was essentially identical 
to that in peptide mapping, except that migration of the tracking dye was 
increased from 10.5 cm to 15 cm to obtain better resolution. Ascending 
chromatography was performed in the modified solvent for 10 hr, 
followed by visualization of radioactive glycopeptides by autoradiography.
The resultant two-dimensional glycopeptide maps for all three 
glycoproteins are shown in Figure 16. The glycopeptide pattern obtained 
for apacid glycoprotein, which contains only N-linked carbohydrates, is 
relatively simple, consisting of four sets of vertically arranged doublets. 
The corresponding pattern obtained for fetuin, which contains both N- and 
O-linked carbohydrates, is quite distinct from that of apacid  
glycoprotein, even though the N-linked carbohydrates from both
a,-acid
*«
•V
i
9P«>
•7
fetuin
Figure 16. Two-dimensional tryptic glycopeptide maps of the lectin 
binding pools of digests of fetuin, apacid glycoprotein, and the gp90 
component of EIAV isolate P3.1-1.
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glycoproteins are essentially identical (Figure 14). This observation 
demonstrates that the peptide to which the carbohydrate is attached 
contributes to the final glycopeptide pattern obtained. The glycopeptide 
pattern obtained for EIAV gp901s the most complex of the three patterns, 
but the resolution of components in the map was still maintained. In 
addition, an identical pattern was obtained for [3H]-glucosamine-1abeled 
gp90 from this isolate under identical conditions (data not shown), 
indicating that radlolodination of amino acids is as effective In detecting 
gp90 glycopeptides in this procedure as in vivo labeling of 
oligosaccharides.
Interestingly, both gp90 and apacid glycoprotein exhibited vertical 
patterns of glycopeptides which electrophorese together, but differ 
slightly in their migration in the chromatography solvent. It is possible 
that these glycopeptide patterns are due to microheterogeneity in the 
carbohydrate moiety, a property which has been documented in several 
glycoproteins (Schmid et a l . , 1977; Schwartzmann et a l . , 1978). Since a 
logical contributor to this microheterogeneity is sialic acid, which Is 
usually found at the non-reducing end of a carbohydrate chain, the effect 
of neuraminidase digestion of the glycopeptides of these two proteins on 
the resultant patterns was determined.
The results of such an experiment are shown in Figure 17. The 
glycopeptide groups seen in the patterns obtained before neuraminidase 
digestion (panel A) were numbered such that 3 direct comparison of the 
patterns could be made. Two of the four groups seen in the untreated
Figure 17. Effects of neuraminidase treatment on glycopeptide
patterns. (A ) Two-dimensional tryptic glycopeptide maps of apacid
glycoprotein and EIAV gp90 from P3.1-1. (B) Two-dimensional 
glycopeptide maps of these two glycoproteins after neuraminidase 
treatment. Glycopeptide groups were assigned arbitrary numbers for 
identification.
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patterns for both glycoproteins were eliminated upon neuraminidase 
digestion (panel B), but the number of individual glycopeptides in the 
remaining groups were totally unaffected. Also, no additional groups 
appeared 1n these maps for either glycoprotein. It therefore appears that 
groups 2 and 4 in both glycopeptide maps represent naturally occurring 
asialo forms of groups 1 and 3, respectively. Thus, sialic acid 
contributes mainly to the electrophoretic behavior of a given glycopeptide 
in this procedure, and not to the generation of vertical patterns. It is 
highly unlikely that these vertical patterns are due to incomplete trypsin 
digestion, since no such vertical patterns are apparent in the peptide 
maps of either glycoprotein. Therefore, these vertical groups are most 
likely due to heterogeneity 1n carbohydrate residues other than sialic 
acid.
With a procedure now available for the analysis of glycosylated 
peptides, the gp90 and gp45 components from the four EIAV isolates 
previously analyzed by two-dimensional peptide mapping were then 
subjected to two-dimensional glycopeptide mapping as just described 
(Figures 18 and 19). All comparisons between isolates were performed 
as in the peptide mapping studies, except that vertical glycopeptide 
groups were compared Instead of individual glycopeptides due to possible 
microheterogeneity. In contrast to the peptide maps obtained for these 
components, in which no two isolates exhibited identical maps, repetition 
of a given glycopeptide pattern is seen In both gp90 and gp45. Two distinct 
patterns were seen for the gp90 component from these Isolates, one
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P3.1-1 P3.1-2
f
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Figure 18. Two-dimensional glycopeptide maps of the gp90 component 
from four EIAV isolates. Arrows and open circles indicate glycopeptide 
additions and deletions, respectively, observed between isolate P3.1-3 
and the remaining isolates.
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P3.1-1 P3.1-2
P3.1-3 P3.1- 4
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Figure 19. Two-dimensional glycopeptide maps of the gp45 component 
from four EIAV isolates. Arrows and open circles indicate glycopeptide 
additions and deletions, respectively, observed when each isolate is 
compared to Its immediate predecessor.
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expressed by P3.1-1, P3.1-2, and P3.1-4, and a very distinct pattern 
expressed by P3.1-3 (Figure 18). Two patterns were also seen for the 
gp45 component, which were expressed in an alternating fashion — one 
pattern exhibited by P3.1-1 and again by P3.1-3, and the other by P3.1-2 
and P3.1-4 (Figure 19). Thus it appears that the glycosylation patterns of 
either glycoprotein may vary between isolates, and that expression of 
differing patterns in the two glycoproteins is independent of one another.
The results of the peptide and glycopeptide mapping studies of the 
four EIAV isolates indicate that structural variation can occur in both 
surface glycoproteins gp90 and gp45, and that this variation is not limited 
to changes in the peptide backbone, but can also occur in the glycosylation 
pattern of both components as well.
d) Two-dimensional peptide mapping — p26, p15, and p9 
The internal EIAV proteins p26, p i5, and p9 from the four 
third-passage isolates were also analyzed by two-dimensional peptide 
mapping. The pi 1 component was not Included in these analyses, since it 
contains no tyrosyl residues and, therefore, cannot be effectively 
radioiodinated (Montelaro et a l . , 1982). The two-dimensional patterns 
for the p26 component from these four isolates, shown in Figure 20, are 
not only identical to each other, but are also Identical to the pattern 
obtained for p26 from prototype EIAV. These results contradict the 
findings of previous structural analysis of p26 from EIAV variants 
recovered months apart from different animals, in which this internal 
polypeptide exhibited structural variation coincident with the return of
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Figure 20. Two-dimensional tryptic peptide maps of the p26 component
from four EIAV isolates.
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EIAV virulence (Montelaro et a l . , 1984a). The only observed difference 
between the two analyses is the type of polyacrylamide gel system used to 
separate the viral polypeptides for subsequent analysis. In the previous 
studies, the p26 component was excised from 10% sodium phosphate gels 
(Parekh e ta l . ,  1980; Montelaro et a l.,  1982), while in the present study, 
15% discontinuous gels were used (Laemmli, 1970). As seen in Figure 21, 
there is a faint protein band in several of the isolates which migrates just 
beneath the p26 component. Since this lower molecular weight band 1s not 
evident in the 10% sodium phosphate gel of these same samples (Figure 
8A ), it is possible that the previous maps obtained for p26 included the 
peptides of this contaminant as well. This hypothesis is supported by the 
fact that structural changes previously noted all corresponded to peptide 
additions (Montelaro et a l . . 1984a). Therefore, it appears that no 
structural variation occurs in the p26 component from EIAV variants 
recovered either months apart from different animals or weeks apart 
from the same animal.
Similar results were obtained for both the p15 (Figure 22) and the p9 
components (Figure 23). The p9 components were partially purified from 
lectin non-binding polypeptide pools by reversed phase HPLC prior to 
separation by SDS-PAGE and peptide mapping to remove contamination by a 
9000 da fragment of p i5 (J. Ball, unpublished results). The peptide 
patterns obtained for each component from the four EIAV isolates were 
identical to each other, suggesting that structural variation does not 
occur in any of the three internal EIAV polypeptides analyzed. Thus it
Figure Z1. SDS-PA6E analysis of the lentil lectin non-binding 
polypeptide pools from four EIAV isolates in a discontinuous system. 
Prototype EIAV was included as a reference.
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P3.1-3
Figure 22. Two-dimensional tryptic peptide maps of the p i5 component
from four EIAV Isolates.
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P3.1-4
Figure 23. Two-dimensional tryptic peptide maps of the p9 component
from four EIAV isolates.
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appears that structural variation observed in EIAV during persistent 
infection is specific for the virion glycoproteins, which are subject to 
immune selection mechanisms.
II. EXTENT OF ANTIGENIC AND STRUCTURAL VARIATION AMONG EIAV ISOLATES
It was previously shown that EIAV isolates recovered months apart 
from different experimentally infected animals exhibited varied 
antigenicity as well as structural variation in the peptide portion of the 
surface antigen gp90 (Montelaro et a l . , 1984a). It has now been 
demonstrated that EIAV variants recovered only weeks apart from the 
same animal also exhibit antigenic variation. In addition, structural 
variation was detected in both surface antigens gp90 and gp45, and this 
variation was seen both In peptide structure and glycosylatlon pattern 
(Salinovich et a l . , 1986). A major unanswered question is the extent of 
variation possible in EIAV. Are there only a small number of antigenic 
strains, as with the three poliovirus serotypes (Diamond et a l . , 1985), or 
do numerous variants exist, as with the over 120 rhinovirus serotypes 
(Cooper et a l.,  1978)? To address this question, structural analysis of 
nine EIAV isolates in addition to prototype virus was performed by peptide 
and glycopeptide mapping of their component polypeptides. In addition, 
antigenic relationships were examined by screening these ten strains with 
a limited panel of glycoprotein-specific monoclonal antibodies.
EIAV Isolates
The panel of isolates for this study included the prototype strain 
and the four strains used in the previous antigenic and structural
90
analyses. In addition, five EIAV strains recovered from a second 
experimentally infected third passage animal were included. This animal 
received the same plasma inoculum as the previous animal, and therefore 
represents a parallel infection. The rectal temperature profiles for both 
animals are shown in Figure 24, and virus isolates were recovered as 
indicated. The first four isolates P3.1-1 through P3.1-4 were recovered 
from an animal exhibiting classical chronic EIA, which is characterized by 
recurring episodes of disease. The Isolates P3.2-I through P3.2-3 also 
represent chronic EIAV, but the disease episodes during which these 
isolates were recovered were separated by only 17 and 26 days, 
respectively. There was a period of 5 months separating isolates P3.2-3 
and P3.2-4, representing the Inapparent stage of the disease where the 
animal is asymptomatic for extended periods but remains a carrier of the 
virus. This set of nine EIAV strains therefore represents a broad range of 
clinical events characteristic to EIA.
Antloenic Studies
Unfortunately, antigenic studies for the five isolates P3.2-I through 
P3.2-5 was limited. Neutralization assays with autologous antisera could 
not be performed, since sufficient serum samples were not taken from 
this animal during the course of disease (A. Orrego, Ph.D. thesis, 
Louisiana State University, Baton Rouge, 1983). In addition, only a very 
limited panel of monoclonal antibodies generated against gp90 from 
prototype virus was available. Despite these limitations, some antigenic 
comparisons could be performed.
91
*— CM
I I
roi Tt
CE
ELU
Q .
XUlJ-
5uUl
s
120 160 200 240 200
P2.1-I DflVS POST INOCULATION
B
EUlD.xUlI-
W
U l
41-
40-
5 9 - -
30'
t
P2.1-1
40
T
00
T “
120
“ 1“
160 200
I I
240 200
DflVS POST INOCULATION
Figure 24. Plots of daily rectal temperature of two parallel-infected 
third passage animalst showing disease episodes and points 8t which virus 
isolates were recovered. (A) Pony P3.1 (B) Pony P3.2.
92
Initially, the polypeptide components of these ten EIAV strains were 
separated by SDS-PAGE of equal quantities (50 >iq ) of each isolate, 
followed by immunoblot analysis with the braodly reactive reference 
antiserum from a naturally infected horse (designated Lady). A typical 
immunoblot pattern thus obtained is shown in Figure 25. The now 
characteristic variation in electrophoretic mobility of both the gp90 and 
gp45 components from all the EIAV strains was clearly evident, while the 
mobility of the p26 component remained constant. This broadly reactive 
antiserum recognized the gp90, gp45, and p26 components from all 
isolates tested, but there was some variation in the relative reactivity of 
this serum with the gp45. component from several of the isolates. This 
antiserum exhibited Its strongest reactivity toward gp45 from isolate 
P3.2-1. This antiserum also exhibited equivalent reacitivity for gp45 
from prototype, P3.1-1, P3.1-2, and P3.2-2 through P3.2-5, but 
exhibited lower reactivity toward this component from both P3.1-3 and 
P3.1-4.
Similar immunoblot experiments were performed with these isolates 
using four available gp90-specific monoclonal antibodies available, the 
results of which are given in Table V. With these monoclonal antibodies, 
isolates P 3 .1-1 through P3.1-4 and P3.2-2 could all be distinguished 
antigenically. Isolate P3.2-5 may also by antigenically distinct, or may 
have the same pattern of reactivity as isolate P3.1-3. Because of the 
limited number of epitopes represented by this panel of antibodies, it was 
not possible to distinguish isolates P3.2-1, P3.2-3, andP3.2-4
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Figure 25. Immunoblot analysis of component polypeptides of 10 EIAV 
strains with a broadly reactive polyclonal antiserum.
T ab le  V. R e ac tiv ity  p a tte rn s  of fo u r m onoclonal antibodies sp ec ific  
fo r  gp90. Monoclonal antibodies were generated against the glycoproteins of 
prototype EIAV, and were then used to screen ten EIAV variants in immunoblot 
analyses. A (+ ) denotes a positive reactivity , a ( - )  denotes no reactivity, and 
a ( + / - )  denotes a very  weak positive reactivity.
MAb prototype P 3 .1 -I P 3 .1 -2  P3.1 -3  P 3 .1 -4  P3.2-1 P 3.2-2 P 3.2-3  P 3.2 -4  P 3.2-5
2 * + -«• + / -  + ND ND ND ND ND
86 + + + + + + — + + +
95 + + + + / -  + - + + +
115 + + + - + + — + +  -
*  Hybridoma cells producing MAb #2 were lost before ascites fluid could be 
produced for the analysis of isolates P3.2-1 through P 3 .2 -5 .
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antigenically. Thus this panel of isolates includes at least 6 antigenic 
EIAV variants. It is interesting to note that MAb #86 recognized gpSO from 
all EIAV isolates tested, and therefore may represent an epitope of gp90 
which is conserved. <•
Structural Analysis — PS.2-1 through P5.2-5
Before total structural variation among the ten EIAV isolates was 
determined, the five isolates P3.Z-1 through P3.2-5 were compared to 
each other. Structural analysis of the component polypeptides of these 
five isolates was performed by two-dimensional peptide and glycopeptide 
mapping, as described above for the previous EIAV strains. Comparisons 
were performed as before, with each isolate being compared to its 
Immediate predecessor, such that P3.2-2 was compared to P3.2-1, and so 
forth. Three to five maps of each isolate were generated, and maps were 
completely reproducible.
The peptide (Figure 26) and glycopeptide (Figure 27) patterns thus 
obtained for the gp90 component from the five isolates revealed some 
very interesting results. Again, peptide additions and deletions occurred 
in the peptide patterns from these isolates, with a notable exception. The 
peptide patterns for gp90 from isolates P3.2-2 and P3.2-3 were identical 
to one another; this Is the first time that any two Identical gp90 peptide 
patterns have been demonstrated. This result may not necessarily 
indicate that the peptide structure for the two molecules is the same, 
since possible structural changes could have occurred in peptides lacking 
tyrosyl or histidyl residues, and therefore do not appear in the msps. In
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Figure 26. Two-dimensional tryptic peptide maps of the gp90 component 
from five EIAV isolates. Arrows and open circles indicate peptide 
additions and deletions, respectively, observed when each isolate is 
compared to its Immediate predecessor.
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Figure 27. Two-dimensional glycopeptide maps of the gp90 component 
from five EIAV isolates. Roman numerals in the upper left corner of each 
pattern refer to the classes described in Table VIII, page 109.
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addition, the glycopeptide patterns for gp90 from these two isolates are 
strikingly different, which again stresses the importance of glycosylation 
pattern differences in variation. Thus, although the peptide patterns 
obtained for gp90 from these two isolates are the same, there is still 
structural variation between the two molecules.
The glycopeptide patterns for the gpQO component from these five 
isolates again showed some repeated patterns (Figure 27), as was 3een in 
the four previous isolates studied. Isolates P3.2-1 and P3.2-4 exhibited a 
similar pattern, which is also the same glycopeptide pattern seen for 
prototype gp90. Isolate P3.2-2 exhibited a pattern seen before in isolates 
P3.1-1, P3.1-2, and P3.1-4, while isolates P3.2-3 and P3.2-5 shared a 
glycopeptide pattern not yet seen In any other Isolates. It Is Interesting 
to note that the three isolates recovered over the shortest time period 
from the same animal all exhibit different gp90 glycopeptide patterns, 
even though two of the three gp90 peptide patterns were the same.
In constrast to the gp90 peptide patterns, no two identical peptide 
patterns were seen for the gp45 component from these five isolates 
(Figure 28). Peptide additions and deletions were observed between each 
pair of successive isolates examined, including P3.2-2 and P3.2-3. In 
contrast, the respective gp45 glycopeptide maps were completely 
identical for each of these five isolates (Figure 29). It therefore appears 
that while comparable variation occurs in the peptide portion of the gp90 
and gp45 components, more variation is seen in gp90 glycopeptide 
patterns than in the corresponding patterns of gp45.
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Figure 28 . Two-dimensional tryptic peptide maps of the gp45 component 
from five EIAV isolates. Arrows and open circles indicate peptide 
additions and deletions, respectively, observed when each isolate is 
compared to its immediate predecessor.
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P3.2-1
%
P3.2-2:
I
*
P3.2-4I P3.2-5
P3.2-3
Figure 29. Two-dimensional glycopeptide maps of the gp45 component
from five EiAV isolates.
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The internal EIAV polypeptides p26, pt5f and p9 from the five isolates 
were also analyzed by two-dimensional tryptic peptide mapping (Figure 
30, panels A, B, and C, respectively). The patterns obtained for p26 
from all five Isolates were Identical to each other, and also Identical to * 
the patterns obtained for this polypeptide from all previous strains, 
including the prototype virus. The same results were observed for both 
p i5 and p9. Thus it appears that structural variation in EIAV during either 
horizontal transmission or persistent Infection 1s restricted to those 
virion polypeptides which are subject to host immune selection 
mechanisms (gp90 and gp45), and that no such structural variation 
occurs in the internal virion polypeptides which are not recognized by the 
host immune defenses during natural Infection.
Comparison of Ten EIAV Isolates
To determine the total number of structurally distinct EIAV strains 
represented in the panel of variants, each isolate was judged on four 
criteria — gp90 peptide pattern, gp90 glycosylatton pattern, gp45 peptide 
pattern, and gp45 glycosylation pattern. For any two isolates to be 
considered as structurally 'identical-, all four structural criteria must 
also be identical. In this way, variations in any one criteria is 
interpreted to mean that the two isolates are structurally distinct.
To facilitate comparison of the peptide patterns obtained for the gp90 
components of the ten EIAV isolates, schematic diagrams of the peptide 
map for each isolate were compiled to yield a composite pattern of all 
peptides observed In msps of this glycoprotein. In this composite map,
P3.2-3pta-a P3.J-4
P3.M; P3.S-3 P3.3-3 f !- P3.2-S
\ „ ,  t  'fesr;
Figure 30. Two-dimensional tryptic peptide maps of the internal
polypeptides p26 (A) ,  pt5 (B), and p9 (C) from five EIAV Isolates.
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shown in Figure 31 f peptides which are common to the gp90 component of 
a]l isolates are represented by filled symbols. The open symbols 
represent those peptides in the gp90 patterns which vary between 
Isolates. All peptides were assigned an arbitrary number for 
identification, and a table was generated showing the distribution of the 
varying peptides among the ten EIAV isolates (Table V I).
Of the 54 gp90 peptide3 considered in this comparison, 27 (or 50%) 
were found to vary among the different EIAV Isolates. The distribution of 
varying peptides was identical only for isolates P3.2-2 and P3.2-3, as was 
mentioned previously. This pattern was not shared by any of the other 
isolates, and no other isolates appeared to share identical patterns.
These ten EIAV strains thus exhibit 9 distinct gp90 peptide patterns. 
Examination of peptide distribution revealed that structural variation in 
gp90 is apparently not accomplished by the accumulation of peptide 
changes. If such accumulation had occurred, a change observed in a 
given isolate would be retained In subsequent Isolates. This phenomenon 
is not observed, as demonstrated by numerous peptides. For example, 
peptides #28, #33, and #44 are present in P3.1-1 gp90, but is absent in 
P 3.1-2. These peptides are again present in P3.1-3 gp90, but are not 
observed In the P3.1-4 pattern. Thus it appears that structural variation 
in gp90 is accomplished by the alternate presence or absence of peptide 
changes in a specific pattern.
Comparisons of isolates recovered from a single animal reveal fewer 
peptide differences than do comparisons of isolates recovered from
Figure 31 . Composite two-dimensional tryptic peptide map of gpQO, 
containing all peptides seen in ten EIAV strains. Arbitrary numbers were 
assigned to each peptide for identification.
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Table VI- Distribution of unique peptides in the two-dimensional patterns 
obtained for the gp9Q component from ten EIAV strains. A (+ ) or ( - )  
indicates the presence or absence, respectively, of a peptide 1n a given 
isolate.
peptide prototype P3.1-1 P3.1-2 P3.1-3 P3.1-4 P32-1 P3.2-2 P32-3 P3J2-4 P32-5
7 + + + + + - + ♦ + +
12 - - + - + - - -
15 - + + + + - + + + -
18 - - - - - - + -
20 + - - - - + + + +
21 - - + - - - +  +  + +
25 - - - + - - -
28 + + - + - + +  +  + +
29 - + + + + •k +  +  + +
30
33
+
+
+
+
+ + + + +
+
35 - + + ♦ + +
36 + + + - + + -f + -
38 - + + - + + + + + -
39 - + + + + + + + + -
40 - ♦ - - + + + + +
43 - + - + - + + + *
44 + + - + + + + + +
45 + + - + + +
46 + + + + + + + + +
47
48
+ + +
+
+ + + + + 
+ + -
+
+
49 + - + - + + +
50 + - + - - +  +  + +
51 + + + - + +  +  + +
52 + + - + - - +  + +
53 + + - + - + +  +  + +
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different animals. In fact, one peptide (#20) was present in all five P3.2 
isolates, but was absent in all four P3.1 Isolates. This may reflect 
structural changes in gp90 associated with adaptation of EIAV to 
replication within a single individual.
A similar composite pattern was constructed for the gp45 maps from 
the ten EIAV Isolates (Figure 32). Of the 46 different peptides considered 
in the comparison, only 12 of these, or 26%, appeared in all ten isolates 
(Table V II). It is not possible to infer from this data that more structural 
variation occurs in gp45, since the proportion of peptides detected by this 
mapping procedure as compared to total peptides has not been 
determined. Of the ten isolates examined, no two exhibited identical gp45 
peptide patterns. Therefore, this panel represents ten structurally 
distinct EiAV strains. As was demonstrated for gp90, it appears that 
structural distinction in gp45 occurs by the presence or absence of 
peptide changes, and not by accumulation of such changes.
Comparison of the glycopeptide maps for the gp90 and gp45 components 
of these isolates was simpler than for the peptide maps, since patterns 
were repeated among Isolates. Table VMI shows a possible classification 
scheme for these patterns. Four different patterns were seen in the gp90 
glycopeptide maps, given as Class I through IV. The most common 
appears to be Class II, which is exhibited by four isolates. The pattern 
exhibited by isolate P3.1 -3 1s unique, and not seen 1n any other Isolate. In 
contrast, there are only two glycopeptide patterns seen for the gp45
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Figure 3 2 . Composite two-dimensional tryptic peptide pattern of gp45, 
containing all peptides seen in ten EIAV strains. Arbitrary numbers were 
assigned to each peptide for Identification.
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Table V II. Distribution of unique peptides in the two-dimensional 
patterns obtained for the gp45 component from ten EIAV isolates. A (+) or 
( - )  indicates the presence or absence, respectively, of a peptide In a 
given isolate.
peptide prototype P3.1-1 P3.1-2 P3.1-3 P3.1-4 P32-1 P32-2 P32-3 P32-4 P32-5
2 - 4 4 4 4 - 4 4 -
3 4 4 4 - 4 4 - - -
6 4 - - - - 4 - 4 4
10 - - 4 4 4 - 4 4 4
11 - - - 4 - 4 4 4 4
12 4 - - 4 - 4 4 4 4
14 - - - •* - - - 4 -
15 - - - - •ft - 4 4 -
17 4 - - 4 4 - - 4 -
10 - - 4 4 4 4 4 4 4
19 - - - - 4 4 - -
20 - - 4 4 4 - - - -
21 4 4 - 4 4 4 4 4
22 - 4 4 4 4 - - 4 -
23 - 4 4 4 4 4 - 4 4
24 4 - - 4 - 4 4 4 4
25 - - - - - - 4 - -
26 4 - - 4 - 4 - - 4
27 - - - - - - 4 4 -
29 - - 4 - 4 - - - -
30 - 4 - - - •ft 4 4 4
31 - 4 - - - - - - -
33 - 4 4 4 4 - - -
35 4 4 - 4 •ft 4 4 - 4
36 4 - - 4 4 4 - 4 4
38 - - 4 4 •ft - - - 4
39 4 - - 4 4 4 4 4 4
40 - - - 4 - - - -
41 4 4 4 4 4 4 - 4 -
42 - 4 4 4 4 4 4 - 4
43 - - - 4 - 4 - 4 -
44 4 4 4 4 - - 4 4
43 - 4 4 4 4 - 4 4 4
46 - - - 4 m - - 4 4
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Table V III .  Classification of EIAV isolates by glycopeptide patterns of 
the gp90 and gp45 components.
A. Classification by gp90 glycopeptide patterns.
Class 1 Class II Class III Class IV
prototype P3.1-1 P3.1-3 P3.2-3
P3.2-1 P3.1-2 P3.2-5
P3.2-4 P3.1-4 
P3.2-2
B. Classification by gp45 glycopeptide patterns.
Class 1 Class II
prototype P3.1-2
P3.1-1 
P3.1-3
P3.2-1 thru P3.2-5
P3.1-4
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component, the first of which seems to be heavily favored. This data may 
indicate that while glycosylation differences in gp90 occur readily the 
glycosylation pattern of gp45 may be important to structure or function 
and therefore must remain rather constant.
This comparison of isolates recovered from parallel experimental 
infections reveraled that no two isolates, regardless of origin, were 
structurally identical. Both animals received the same inoculum, but 
parallel peptide or glycopeptide patterns were not observed. Thus the 
evolution of variation in EIAV in the two infections occurred with no 
evidence of a predictable pattern. This may reflect a very large number 
of possible variations in EIAV.
III .  SEQUENCE OF THE EIAV env GENE — COMPUTER MODELING OF od90 AND 
OP45
Recently, the entire envelope gene sequence for prototype EIAV was 
determined for a cloned proviral segment recovered from the DNA of 
persistently infected fetal equine kidney cells (Rushlow et al. 1986). This 
DNA sequence was then "translated" by computer into the predicted amino 
acid sequence for the entire envelope polyprotein. Proteolytic processing 
sites for the production of gp90 and gp45 were tentatively located, as well 
as all possible N-linked glycosylation sites. The "processed" amino acid 
sequences for the gp90 and gp45 polypeptides were then analyzed by 
several predictive computer programs, and a possible structural 
conformation was predicted for these two EIAV glycoproteins.
I l l
Analysis of the envelope Dolvprote.in_sequence
The entire amino acid sequence for the envelope polyprotein of EIAV is 
given in Figure 33, and is derived from the proviral DNA sequence 
determined previously (Rushlow et a l . , 1986). The amino terminus of the 
predicted polyprotein contains a region of 21 hydrophobic or uncharged 
residues, which precedes a region of charged residues (E-K-S-K-C-E-E). 
These properties are consistant with a signal sequence (Perlman and 
Halvorsen, 1983), which is removed by proteolytic cleavage to produce a 
gp90 amino terminus of glutamate. Recent end group analysis of purified 
gp90 from prototype EIAV indicates a probable amino terminal residue of 
glutamate or glutamine, which supports this prediction (V. Rao and J. 
Ball, unpublished results). The gp90 portion of the polyprotein extends 
for 424 amino acids, ending with a conserved arginine-rich segment 
(R-H-K-R). This segment is analogous to the cleavage sites reported for 
most retrovirus envelope precursors (Seiki et a l. ,  1983; Herr et a l., 
1984; Sodroskf et a l . , 1984). Thus, the processed gp90 polypeptide 
consists of residues 21 -  444, and the gp45 polypeptide consists of 
residues 445 -  859.
Analysis of potential N-linked glycosylation sites revealed 13 such 
N-X-S/T sites within gp90, snd 5 such sites in gp45. It is Interesting to 
note that the glycosylation sites in gp90 are very evenly distributed 
throughout the molecule, but all but one of these sites are found in the 
N-terminal region of gp45.
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Figure 33 . Amino acid sequence for the envelope polyprotein of 
prototype EIAV. The signal sequence cleavage site (1) and precursor 
cleavage (2) are indicated by arrows. Potential glycosylation sites are 
indicated by diamonds.
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Prediction of transmembrane regions
According to the algorithm developed by Kyte and Doolittle (1982), 
transmembrane regions can be predicted in amino acid sequences. For a 
stretch to qualify as transmembrane, it must consist of at least 19 
consecutive amino acids, and the average hydrophobicity over the entire 
stretch must be greater than 1.6. To determine possible transmembrane 
segments in gp90 and gp45, hydrophobicity plots were generated for these 
sequences (Figures 34 and 35). Possible hydrophobic stretches of at 
least 19 amino acids were located by visual analysis of the profiles, after 
which the average hydrophobicity wss calculated for each possible 
sequence.
Four such hydrophobic amino acid sequences exist in the profile 
generated for gp45 (residues 446 -  465, 617 -  636, 787 -  806, and 816 -  
834). The average hydrophobic value for these four sequences are 2.14, 
2.17, 2.19, and 1.87, respectively, and therefore all four qualify as 
possible transmembrane regions. No such possible sequences are 
present in the profile for gp90, which exhibits an overall hydrophilic 
character, it appears from this analysis that gp90 itself has no 
association with the lipid membrane surrounding the virus, and must 
therefore be attached by interaction with gp45. This interaction has been 
proven previously to nfil involve disulfide linkages between the two 
glycoproteins (Parekh et a l., 1980).
Prediction of antioenic sites
It has been postulated by Hopp and Woods (1981) that possible
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Figure 34. Hydropathic character of the predicted gp9Q polypeptide 
sequence. Hydrophobic character is represented as positive, and 
hydrophilic character is represented as negative. Numbering is the same 
as in Figure 33.
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Figure 35 . Hydropathic character of the predicted gp45 polypeptide 
sequence. Hydrophobic character is represented as positive, and 
hydrophilic character is represented as negative. Numbering is the same 
as in Figure 33.
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antigenic sites may coincide with predicted regions of hydrophilicity within 
a polypeptide sequence. They found that the region of highest hydrophilic 
character coincided with a proven antigenic site in a large number of 
proteins examined. In addition, other hydrophilic regions may or may not 
be antigenic because of their probable position at the surface of the 
protein.
The highest region of hydrophilic character in gp90 is located between 
residues 5 7 -7 1 , with a peak at residue 66 (Figure 34). There are no 
possible glycosylation sites within this region, indicating that the peptide 
backbone is not masked by carbohydrate. Other hydrophilic regions exist 
at numerous positions along the sequence, and account for a large portion 
of the gp90 polypeptide. Thus there Is a large number of possible epitopes 
predicted by this method.
The major region of predicted hydrophilic character in gp45 occurs 
between residues 691 -  721 (Figure 35) and may also represent an 
antigenic site. However, since the exact orientation of gp45 in the lipid is 
not known, this region may be exposed to the inside surface of the 
membrane, and although antigenic may not be accessible to antibody 
during natural infection.
Determination of secondary structure
The algorithms developed by Chou and Fasman (1974, 1978) for the 
determination of secondary protein structure were employed as a final 
analysis of the gp90 and gp45 polypeptide sequences. It must be 
remembered that the reliability of these programs to assign correct
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Figure 36 . Secondary structure of the gp90 polypeptide predicted by the 
Chou and Fasman method (1974, 1978). A (-2) represents a residue in 
helical structure, a ( a ) represents a residue 1n sheet structure, a (—) 
represents a residue in random coil, chain reversals indicate turns, and 
diamonds represent possible glycosylation sites. Numbering is the same 
as in Figure 33.
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Figure 37. Secondary structure of the gp45 polypeptide predicted by the 
Chou and Fasman method (1974, 1978). A (A) represents a residue in 
helical structure, a (a ) represents a residue 1n sheet structure, a (—) 
represents a residue in random coil, chain reversals indicate turns, and 
diamonds represent possible glycosylation sites. Numbering is the same 
as in Figure 33.
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conformation to a given residue is in the range of 5* to 70* accuracy, and 
any structure based on this analysis can only be considered an 
approximation.
The predicted structures for gp90 and gp45 are given in Figures 36 and 
37, respectively. The gp90 polypeptide is predicted to consist of 24* 
or-helix and 22* 0-sheet structure, which is consistant with a compact, 
globular conformation (Chou and Fasman, 1974, 1978). The or-helix 
content of gp45 is comparable to that of gp90, at 23*. There Is a slightly 
higher 0-sheet content predicted for gp45 (30*), which may indicate that 
gp45 is more structurally constrained than gp90 due to greater intrachain 
hydrogen bonding. However, the nature of the interaction between gp90 
and gp45 is not obvious from these predicted structures. Therefore very 
important nuances in the specific protein folding of gp90 and gp45 may be 
overlooked in a direct interpretation of the predicted structures.
CHAPTER 4 
DISCUSSION
The experiments described in these investigations have enabled us to 
determine the following:
1) An approximate minimum time span required for the emergence of 
novel antigenic and structural variants of E1AV during persistent infection 
in a single animal.
2) The contribution of the various EiAV polypeptide components to 
antigenic and structural variation during persistent infection in the same 
animal.
3) An estimation of the minimum number of possible distinct EIAV 
variants and their pattern of evolution.
4) The hydropathic character and general conformation of the EIAV 
surface antigens gp90 and gp45.
Previous investigations into antigenic and structural variation in EIAV 
involved several isolates recovered during the first and last disease 
episodes from three experimentally infected animals (Montelaro et a l . , 
1984a). These isolates were distinguished antigenically in neutralization 
assays using autologous antisera and were shown to exhibit structural 
changes in the peptide portion of the major surface antigen, gp90, as 
indicated by two-dimensional tryptic peptide mapping. This was the first
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experimental evidence to support the hypothesis of antigenic variation as a 
mechanism for EIAV persistence since its proposal 11 years previously 
(K onoetal., 1973).
Since EIAV isolates recovered from the same animal in these studies '  
were separated by up to 6.5 months and as many as four intervening 
disease episodes, no minimum estimate of the time required for the 
emergence of novel antigenic and structrual variants could be 
determined. In addition, no structural analysis of the gp45 surface 
antigen from these isolates was possible due to high background in the 
mapping technique, snd techniques for the analysis of the carbohydrate 
moieties of these glycoproteins had not yet been developed.
In the present Investigations, nine EIAV isolates recovered from 
sequential disease episodes in two ponies infected in parallel with the 
same plasma inoculum (Figure 24) were examined in both serological and 
structural analyses, as was the prototype strain. All four isolates from 
one animal (P3.1-1 through P3.1-4) could be antigentcally distinguished 
by neutralization assays employing antisera collected from the ssme 
animal between disease episodes (Salinovich et a l . , 1986), indicating that 
distinct antigenic variants are associated with each clinical episode. In 
addition, these same four isolates could be distinguished antigenically by 
reactivity of their gp90 glycoprotein component in immunoblot analyses 
with a panel of gp90-specific monoclonal antibodies. In contrast, all 
gp45-specific monoclonal antibodies tested reacted with this component 
from all nine EIAV strains, as well as the prototype virus. These results
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may indicate that although gp45 is strongly recognized by the host during 
infection, this glycoprotein does not contribute greatly to observed 
antigenic variation in EIAV. The gp90 component thus appears to be 
responsible for both induction of neutralizing antibody 1n the host, as well 
as the generation of antigenic variants. Further studies with a broader 
panel of monoclonal antibodies is necessary before the relative 
contribution of these two glycoproteins to antigenic variation in EIAV can 
be accurately assessed.
No neutralization data was available for the five isolates from the 
second animal (P3.2-! through P3.2-5), and antigenic distinction by 
reactivity with glycoprotein-specific monoclonal antibodies was hampered 
by the small number of antibodies available. However, two of these 
isolates, P3.2-2 and P3.2-5, could be distinguished from each other and 
from all remaining P3.1 and P3.2 isolates on the basis of the reactivity of 
their respective gp90 components in immunoblot analysis with specific 
monoclonal antibodies. Even though the analysts was admittedly limited, 
it appears that this panel often EIAV isolates represents at least seven 
antigenic variants. These results indicate that antigenic variation can 
occur in EIAV isolates recovered from disease episodes separated by only 
17 days (the time span between recovery of isolates P3.2-1 and P3.2-2), 
and that this variation is determined predominantly by changes in specific 
epitopes of the gp90 molecule. Thus, the time frame required for 
antigenic variation in EIAV is considerably shorter than that reported for 
visna virus, which requires one to two years for the emergence of
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antigenic variants in the persistently infected animal (Scott et a l . , 1979; 
Clements et a l . , 1980),
Two-dimensional tryptic peptide mapping of the major polypeptide 
components from these ten EIAV strains was facilitated by the use of 
discontinuous SDS-PAGE (Laemmli 1970) for their separation and isolation 
prior to mapping. In this gel system, the gp90 component could be 
completely separated from a closely-migrating cellular glycoprotein, 
therefore decreasing the possibility of contamination in the subsequent 
peptide analysis. It was also possible to obtain gp45 in a pure form from 
this gel system, thus allowing its analysis for the first time.
As demonstrated in Table VII, no two isolates studied exhibited 
Identical gp45 peptide patterns, regardless of origin. Similar results 
were observed for the gp90 peptide patterns, with the notable exception of 
isolates P3.2-2 and P3.2-3, which exhibited identical patterns. Although 
these ten isolates apparently represent only 7 antioenicallv distinct 
classes, all are structurally distinct by virtue of their surface 
glycoproteins. Thus, structural variation in the surface glycoproteins of 
EIAV during persistent infection can apparently occur as rapidly as 
antigenic variation.
The structural variation seen In the gp90 and gp45 peptide maps 
appeared to be much greater when comparing isolates recovered from 
different animals than when comparing isolates recovered from the same 
animal. It is also interesting to note that although both animals in this 
study received the Identical virus inoculum, the EIAV variants associated
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with the first disease episode in each animal (isolates P3.1-1 and P3.2-1) 
exhibited very different gp90 and gp45 peptide patterns. This may 
represent structural changes necessary for adaptation to replication in 
the two different animals. Structural variation in the gp90 polypeptide 
has been previously demonstrated upon horizontal passage of the virus in 
animals (Montelaro et a l . , 1984a), thus paralleling the results obtained 
here.
Similar two-dimensional tryptic peptide analysis of the Internal 
nonglycosylated polypeptides p26, p i5, and p9 demonstrated that no 
detectable structural variation had occurred in any of the EIAV isolates 
examined, it had previously been reported that structural variation 
occurred in the p26 component of EIAV Isolates concurrently with the 
return of virulence after prolonged passage of the virus in tissue culture 
(Montelaro et a l . , 1984a). This variation was shown to be due to 
concurrent mapping of p26 and a cellular contaminant which comigrate in 
the SDS-PAGE system used to separate viral components in the original 
study. The use of the discontinuous SDS-PAGE system in the present 
studies allowed for the separation of these two polypeptides such that p26 
could be obtained in pure form for peptide analysis. Thus none of the 
internal polypeptides of EIAV examined contribute to structural variation 
in EIAV.
With the development of modifications to the peptide mapping 
procedure, glycosylated peptides of gp90 and gp45 could finally be 
analyzed (Salinovich and Montelaro, 1986). Such analysis of the
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carbohydrate moiety has not been previously possible, since conventional 
techniques require relatively large quantities of pure substrate, which 
are not available for either of the EIAV surface glycoproteins. In 
addition, analysis of carbohydrate by successive cycles of specific 
glycosidase digestion and gel filtration analysis, although very useful in 
some situations, offers relatively low resolution and gives no information 
as to the point of attachment (Hunt and Wright, 1981, 1983). The 
glycopeptlde mapping technique developed here was capable of resolving 
glycosylated peptides such that a distinctive 'fingerprint* could be 
generated, in which the peptide to which the carbohydrate is attached also 
contributes to the final pattern obtained. Such minor changes as removal 
of sialic acid residues could also be readily detected. Glycopeptlde 
fingerprints from the gp90 and gp45 components of the nine isolates were 
thus generated and compared to determine possible variations in 
glycosylation.
In contrast to the peptide patterns, identical glycopeptlde patterns 
were observed for the gp90 and gp45 components from several of the 
isolates. Four possible glycopeptide patterns were exhibited by gp90, and 
only two patterns by gp45. It is interesting to note that changes in 
glycosylation do not occur often in gp45, and that this glycoprotein also 
does not appear to contribute greatly to EIAV antigenic variation.
However, glycosylation patterns appear to be very important in antigenic 
variation in gp9Q. Isolates P 3 .2 -I, P3.2-2, and P3.2-3 were recovered 
from the same animal only 17 and 26 days apart, respectively, and the
131
three gp90 components from these isolates exhibited distinct glycosylation 
patterns. The importance of this carbohydrate contribution is increased 
by the fact that two of these three isolates (P3.2-2 and P3.2-3) exhibited 
identical gp90 peptide patterns. These two latter Isolates were shown to 
be antigenically distinct by virtue of their reactivity with gp90-specific 
monoclonal antibodies. These observations are consistent with the 
findings of Alexander and Elder (1985), which demonstrated the 
importance of glycosylation to the antigenic characteristics of viral 
glycoproteins. In these studies, antibodies raised against intact Rauscher 
murine leukemia virus (R-MuLV) gp70 were generally directed toward the 
carbohydrate of this antigen. Binding avidity of these antibodies to intact 
gp70 was lower than that observed for corresponding antibodies generated 
against the gp70 polypeptide backbone. Thus glycosylation may 
effectively ’ mask’ highly antigenic sites along the peptide structure, 
leaving the immune system of the host to produce low avidity antibodies to 
the glycoprotein antigens of the infecting virus. This may well be the case 
in EIAV, where at least 10% to 15% of the host's immune response to gp90 
during natural infection is directed toward the carbohydrate (Montelaro et 
a l., 1984a). In addition, virus neutralizing antibodies in the naturally 
Infected animal are of relatively low titers (Orrego et a l.,  1982).
It is highly unlikely that the observed peptide and glycopeptlde changes 
are due to artifacts of the mapping procedure. Three to five patterns 
were generated for the gp90 and gp45 components from each isolate, and 
the observed peptide alterations were completely reproducible. The
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possibility of contamination is rather small, since concurrent analysis of 
two or more 90,000 or 45,000 da proteins would result in a very large 
number of peptide alterations, all of which would be additions. Also, the 
fact that two isolates exhibited identical gp90 patterns argues strongly * 
against the presence of contamination. All virus strains were cloned by 
limiting dilution prior to propagation in tissue culture and subsequent 
biochemical analysis, so the possibility of mapping the gp90 or gp45 
component from two or more strains concurrently was minimized.
It should be emphasized that the peptide and glycopeptide mapping 
procedures used here provide only a minimum estimate of the total 
structural variation possible in EIAV. Only those fragments which contain 
tyrosyl or histidyl residues susceptible to radloiodination are detected. 
Thus the actual level of structural variation is probably much greater, 
and can only be quantited by determining the amino acid sequences of the 
glycoproteins from these isolates.
The fact that peptide and glycopeptlde alterations were observed in 
isolates recovered only 17 days apart from the same animal, but no such 
alterations were observed after replication of the virus in tissue culture 
for up to six months, suggests that immune selection pressures, absent in 
tissue culture but prominent in the natural host, play a significant role In 
the emergence of antigenic and structural EIAV variants during persistent 
infection. In support of this hypothesis is the lack of detectable variation 
in the internal EIAV polypeptides, which are protected from the host's 
immune defenses in the intact virion. Any structural changes in these
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internal polypeptides arising from mutations thus offers no special growth 
advantage and therefore are not selected by immune pressures.
These observations raise the question of the origin of structural 
variation in EIAV glycoprotein antigens. Payne et al. (1984) 
demonstrated that the genomes of EIAV isolates recovered months apart 
from different experimentally infected animals exhibited altered RNase
Tj-resistent oligonucleotide patterns, and that the number of observed
alterations was conslstant with the occurrance of point mutations in the 
respective EIAV genomes. Recently, the genomes of EIAV isolates P3.1-1 
through P3.1-4 were also analyzed by this procedure (Salinovich et a l. ,  
1986), and the results showed that genomic alterations occurred 
concurrently with structural and antigenic variation in the surface 
glycoproteins, in fact, most of the altered oligonucleotides present in 
isolate P3.1-3 could be localized to the 3' region of the genome, 
corresponding to the env gene which codes for the gp90 and gp45 
components, it is unlikely that recombinational events were responsible 
for the observed oligonucleotide alterations, since endogenous 
ElAV-related sequences with which recombination could occur have not 
been found in normal horse DNA or the DNA of other members of the genus 
Equus (Rice et a l.,  1978). Also, one would expect a high number of 
oligonucleotide alterations in the event of recombination, which was not 
observed in these experiments.
Similar studies have demonstrated the occurrance of point mutations in 
the genomes of antigenic variants of visna virus, and these alterations
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have also been localized to the 3' end, or env region, of the viral genome 
(Clements et a l. ,  1980). In addition, sequence analysis of several 
isolates of HTLV-III/LAV have demonstrated the presence of variation, 
which appears to be concentrated in the env gene, and these alterations 
are again consistent with the occurrance of point mutations and not 
recombinational events (Sanchez-Pescador et a l . , 1985; Ratner et a l . , 
1985; Wain-Hobson et a l . , 1985). Thus it appears that variation in the env 
gene products Is characteristic of members of the lentivirus subfamily.
The genomic and peptide alterations observed in antigenic variants of 
visna virus recovered from the same animal were found to be cumulative, 
such that all previous alterations were exhibited by a given isolate. The 
structural changes observed in the nine EIAV Isolates studied here were 
not cumulative, but appeared to originate from the expression of a 
specific subset of possible variations (Payne et a l . , 1984; Salinovich et 
a l., 1986). This was characterized by the presence or absense of 
specific peptides in the two-dimensional tryptic maps of gp90 and gp45, or
RNase Tpresistant oligonucleotides in maps of the respective genomes.
These results may indicate the presence of mutational 'hot spots' in the 
EIAV genome, which are localized to the env gene coding for gp90 and 
gp45. Such regions have been located In the gene coding for the 
hemagglutinin for type C influenza viruses, which also exhibit 
noncumulative variation (Buonagurio et a l.,  1985). Thus the mechanisms 
by which variation is introduced into EIAV and visna virus may be 
different.
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, From these results, a possible sequence of events can be visualized 
for the emergence of antigenic and structural variants of EIAV during 
persistent infection. Upon initial infection, the virus integrates into the 
host genome and begins active replication, Indicated by the high plasma 
viremia observed during the first 15 to 40 days post infection (Issel and 
Coggins, 1979; Orrego et a l . , 1982). During this viremia, the animal 
mounts an apparently competent immune response to virus in the plasma. 
Most of the virus 1s cleared from the animal, but there may be a minor 
population of mutant viruses present, either arising during replication in 
the initial viremia, or present in the original inoculum. Once the initial 
viral species is eliminated, the animal remains apparently healthy until 
one or more of the mutant variants can establish itself and replicate In 
sufficient quantities to produce a second burst of viremia and 
accompanying clinical symptoms. These mutants, since not cleared by 
the initial immune response, are not neutralized, and the animal must 
mount a separate response against the new variant(s).
There are several factors which may contribute to the recurring 
nature of EIA. The initial inoculum may well contain a mixture of virus 
variants which can replicate equally well in the infected animal.
However, It Is logical to assume that all variants contributing to the fnitial 
acute disease episode will be eliminated by the host's immune defenses. 
The fact that the original inoculum may contain a mixture of variants again 
emphasizes that EIAV is a highly mutable virus. In addition, there exists 
no precedent for a virus system In which minor variant populations are
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sequentially selected by immune responses.
Another factor in the recurrance of EIA is possible host restriction of 
EIAV replication, similar to that documented in visna virus. This virus 
initially infects monocytes and other macrophage precursors, which are 
not permissive to virus replication. However, upon maturity of 
monocytes to macrophages, this restiction is eliminated and the virus is 
able to replicate and induce disease (Gendelman et a l . , 1985). This 
sequestering of visna virus 1n monocytes effectively prevents detection of 
the virus by host immunosurveillance mechanisms. A similar mechanism 
of host restriction may also be present in EIAV, which has been shown to 
also replicate within monocytes and macrophages (McGuire et a l . , 1971; 
llshlmi et a l., 1972). Unfortunately, very little Is known about the 
molecular events of replication of EIAV in the natural host, and insight 
into this aspect EIAV variation awaits such information.
Once the predominant virus variant associated with the initial burst of 
viremia Is eliminated, there may be some very low levels of replication of 
the integrated provirus even under restrictive host conditions. Mutations 
may be introduced into the genome of the replicating virus, and a viable 
antigenic variant may result. Once the restriction to replication is lifted, 
the new variant is not recognized by the neutralizing antibody raised 
against the initial variant and can therefore replicate in levels high enough 
to produce a new cycle of disease. The high variability of frequency of 
disease episodes seen in both natural and experimental infections could 
arise from the varying probabilities that a given mutation will give rise to
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an antigenic variant that is not only capable of escaping neutralization by 
existing antibody but is also replication competent and infective.
Whatever the mechanism, it appears that E1AV is a highly mutable 
virus. However, only a limited number of structural changes are allowed 
to occur in the glycoproteins to produce antigenic variants before function 
is impaired and virus viability is lost, such that a finite number of total 
serotypes of EIAV can exist. The ten EIAV strains included in the present 
studies have been shown to represent at least seven different antigenic 
strains, and the fact that these isolates were all shown to structurally 
distinct increases the possibility that each is in actuality an antigenic 
variant (Salinovich et at. ,  1986). No pattern of predicatable evolution of 
EIAV could be determined from examination of Isolates from two parallel 
infections, suggesting a large number of variants. Thus, EIAV may 
resemble the rhinoviruses, which have been shown to exist in over 120 
distinct 3erotypes (Cooper et a l.,  1978).
To aid in the production of effective vaccine protocols for the control 
of EIA, the amino acid sequence of the envelope polyprotein, as predicted 
from the nucleic acid sequence of a proviral segment from prototype 
EIAV, was subjected to several types of computer modeling analyses. 
These Included location of proteolytic processing sites and possible 
N-linked glycosylation sites, determination of hydropathic character 
(Kyte and Doolittle, 1982), and prediction of secondary structure (Chou 
and Fasman, 1974, 1978). The entire envelope precursor consisted of 
859 amino acids (Rushlow et a l.,  1986), the first 20 amino acids of which
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represent a classic signal sequence for membrane-associated 
glycoproteins (Perlman and Halvorsen, 1983). Amino acids 21 through
444 comprised the predicted gp90 amino acid sequence, which is 
terminated by a four-residue proteolytic cleavage signal (R-H-K-R) for 9 
the production of gp90 and gp45 from the polypeptide precursor. Residues
445 through 859 represent the gp45 amino acid sequence. Thirteen 
possible glycosylation sites are evenly distributed throughout the gp90 
sequence, which Is substantiated by previous work indicating that gp901s 
rather heavily glycosylated (Parekh et a l . , 1980; Montelaro et a l . ,
1982). In contrast, only five such sites are observed in gp45, and four of 
the five sites are clustered at the N-terminus of this molecule.
Hydropathfc analysis of these two polypeptides Indicates that gp90 has a 
rather hydrophilic nature, while gp45 is relatively hydrophibic and is thus 
probably associated with the lipid membrane of the virion. Prediction of 
secondary structure (Chou and Fasman, 1974, 1978) indicates that gp90 is 
globular in shape and may possess intricate folding, while gp45 appears to 
be more restricted in conformation.
These results are very similar to those reported for the envelope 
glycoproteins of both visna virus and HTLV-lli/LAV (Sonigo et a l . , 1985; 
Sanchez-Pescador et a l . , 1985; Ratner et a l . , 1985). It has been shown 
in both these viruses that the larger glycoprotein derived from the 
N-terminus of the polyprotein is hydrophilic and globular, and is heavily 
glycosylated along its entire length. The smaller glycoprotein derived 
from the C-terminus of the polyprotein Is lightly glycosylated in the
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N-terminal region, and due to its hydrophobic nature, it is most probably 
associated with the lipid bilayer.
From these considerations alone, there is no apparent association of 
gp90 with the lipid envelope of the virus, such that some association must 
exist between this glycoprotein and gp45 in the mature virion. It has been 
previously shown that no disulfide bridges exist between these two 
glycoproteins (Montelaro et a l.,  1982). To investigate the nature of this 
crucial interaction, the predicted secondary structures of both the gp9Q 
and gp45 sequences were re-examined closely.
The regions consisting of residues 411 -  422, 440 -  444, 449 -  465, 471 
-  482, and 518 -  530 all have high probabilities of being in either the 
helical or sheet conformation (Table IX). Of these regions, only residues 
484 -  489 have a higher tendency to be in a sheet conformation; the rest 
tend to be helical. A similar case is seen in the 29-residue peptide 
hoarmone, glucagon. Residues 19-27 in glucagon are predicted by this 
method to be helical, but the region also has a high tendency to be in a 
sheet conformation (Chou and Fasman, 1978). It has been found that in 
dilute solution, this region of glucagon is indeed helical. However, when 
the concentration of glucagon is greatly increased, this region reforms 
Into a sheet structure, which enters Into intermolecular hydrogen bonding 
to the corresponding region of a second glucagon molecule (Chou and 
Fasman, 1978). This reversion might also occur in the folding of the 
mature gp90/gp45 complex.
As demonstrated in Figure 38, if all six regions of ambiguous
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Table IX . Relative probabilities of amino acid sequences to exist in 
either a helix or sheet conformation. Probabilities for segments were 
determined by averaging the individual amino acid probabilities over the 
entire segment. Any values above 1.0 are considered strong 
probabilities. <Pa> represents the probability of helical conformation,
and <Pp> represents the probability of sheet conformation.
PEPTIDE <p«> <Pp>
411 -  422 (gp90) 1.102 0.902
440- 444 (gp90) 0.978 0.970
4 49 - 465 (gp45) 1.219 1.145
471 -  462 (gp45) 1.177 1.092
484 -  469 (gp45) 0.868 1.037
518 - 530 (gp45) 1.209 0.975
141
Figure 38. Possible structural interaction between the carboxy 
terminus of gp90 and the amino terminus of gp45. (A ) Structure 
predicted by strict application of the Chou-Fasman rules. (B) Structure 
predicted if all ambiguous regions are assigned sheet conformation. A (4) 
represents helix, a (A) represents sheet, a H  represents random coil, 
chain reversals indicate turns, and diamonds represent glycosylation 
sites. Numbering is the same as in Figure 33.
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conformation are shown to be in a sheet structure, extensive hydrogen 
bonding may form between the C-terminal region of gp90 and the 
N-terminal region of gp45. In addition, possible glycosylation at residues 
406, 411, 483, and 490 will mark this region as exposed to the surface of 
the structure, thus allowing access of the protease to the polypeptide 
cleavage site. For this hypothesis to be valid, the predicted 
transmembrane segment from residues 446 to 465 in gp45 must actually
be involved in this sheet structure. The relative amounts of a-helix and
P-sheet predicted for either form of gp90 are not greatly distinct, making 
experimental determination of actual structure difficult. However, the
difference in amounts of p-sheet predicted for the two forms of gp45 is 
substantial enough (a change from 30X to 40£) to be distinguished 
experimentally by circular dichroism.
Figure 39 shows a possible structure for both gp90 and gp45, which 
includes placement in the membrane and Interaction of the two 
glycoproteins. Note that 4 of the 5 possible glycosylation sites on the 
gp45 molecule are exposed to the outside of the membrane, and the fifth 
site is predicted not to be glycosylated. The gp45 molecule serves to 
anchor the complex to the membrane, while the entire gp90 molecule Is 
outside the membrane. The extensive sheet structure provides the 
association necessary to retain gp90 in the mature virion. It should be 
noted that any conditions which would destroy this hydrogen bonding would 
release gp90 from the virion, which has been found experimentally to
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8P45
virion 
exterior
lipid
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Figure 39. Proposed structural domain model for the gp90/gp45 
complex in mature EIA virions. Sheet structure and glycosylation sites 
are indicated as in Figure 36.
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characteristic of this glycoprotein (Parekh et a l.,  1980; Montelaro et a l. ,  
1982).
This model is consistent with observed characteristics of both gp90 and 
gp45. By analogy with other retroviruses (Schafer and Bolognesi, 1977), 
gp90 is important not only in host cell recognition but also in the induction 
of neutralizing antibodies. This latter point is substantiated by the 
results of the present study. According to this model, this component is 
situated entirely outside the lipid membrane. The heavy glycosylation of 
gp90 may mask highly antigenic sites on the peptide backbone, while 
presenting the much less antigenic carbohydrate to the host's immune 
system. Minor variations in peptide structure or especially in 
glycosylation of gp90 would lead to possible antigenic variation in the 
virus, which has also been demonstrated in the present studies. The fact 
that very littte variation is observed in the gp45 glycopeptide patterns 
may indicate that glycosylation is very important to virus viability. The 
glycosylation of gp45, according to the model, apparently designates the 
orientation of the gp90/gp45 complex in the membrane.
This predicted model for the gp90/gp45 complex provides a reference 
point for the development of successful vaccination protocols for the 
control of EIAV. Those regions of gp90 with high hydrophilic character 
are likely targets for antibody production, since these regions are 
probably exposed to the surface of the molecule (Hopp and Woods, 1981). 
The importance of glycosylation to the antigenic reactivity of gp90 cannot 
be overlooked, such that synthetic peptides used to induce possible
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neutralizing antibody must be glycosylated to the same extent as in the 
native virus. Another possible target for antibody production may be the 
region of interaction between the gp90 and gp45 molecules, since binding 
of antibody to this region could conceivably cause a conformational change 
resulting in the release of gp90 from the virion and subsequent loss of 
infectivity.
However, a key determinant in the control of EIAV is the identification 
of those cells or tissues In the host in which the virus is sequestered 
during inapparent stages of the disease. Once this is elucidated, more 
effective procedures for the control of this economically important 
disease may be developed.
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APPENDIX I
LIST OF ABBREVIATIONS
AGID Agar gel immunodiffusion
AIDS Acquired immune deficiency syndrome
BSA Bovine serum albumin
CAEV Caprine arthritis encephalitis virus
DNA Deoxyribonucleic acid
DOC Deoxycholate
DPCC Diphenyl carbamyl chloride
EDTA Ethylene diamine tetraacetic acid
EIA Equine infectious anemia
EIAV Equine infectious anemia virus
FEK Fetal equine kidney
FLV Friend murine leukemia virus
HA Hemagglutinin
HAT Hypoxanthine/Aminopterine/Thymidine
HEPES N"2-hydroxyethylp1perizine-N'-2-ethane suif0n|C aci<j
HPLC High pressure liquid chromatography
HTLV-I Human T-cell leukemia virus type 1
HTLV-II Human T-cell leukemia virus type II
HTLV-I II Human T-cell lymphotropic virus type III
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MEM Minimal essential medium
PAGE Polyacrylamide gel electrophoresis
POPOP 1,4-biS”[2-(-4-methyl-5-phenyloxazolyl)]-benzene
PPO 2,5-dtphenyloxazole
PPV progressive pneumonia virus
RNA ribonucleic acid
RSV Rous sarcoma virus
TCA Triclhoroacettc acid
TEMED N,N,N',N'-tetramethylene diamine
TFA Trifluoroacetic acid
Tris tris (hydroxy methyl) aminoethane
APPENDIX II
Three-letter and one-letter designations for the 20 common amino acids.
Amino Acid Three-letter One-letter
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartate Asp D
Cysteine Cys C
Glutamate Glu E
Glycine Gly G
Histidine Hi a H
Isoleucine lie 1
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
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APPENDIX I I I
Parameters assigned for computer modeling of the amino acid 
sequence of the env gene.
A. Hydropathic values assigned to the 20 common amino acid residues 
for determination of hydrophobic and hydrophilic protein regions using the 
algorithm of Kyte and Doolittle (1982).
Residue Value Residue Value
Alanine 1.800 Leucine 3.800
Arginine -4.500 Lysine -3.900
Asparagine -3.500 Methionine 1.900
Aspartate -3.500 Phenylalanine 2.800
Cysteine 2.500 Proline -1.600
Glutamate -3.500 Serine -0.800
Glutamine -3.500 Threonine -0.700
Glycine -3.500 Tryptophan -0.900
Histidine -3.200 Tyrosine -1.300
Isoleucine 4.500 Valine 4.200
A positive value denotes a hydrophobic character, and a negative 
character denotes a hydrophilic character.
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B. Conformational probabilities for the 20 amino acid residues for the
prediction ofa-helix andp-sheet by the methods of Chou andFasman 
(1974,1978).
Residue p« PP Residue Proc PP
Ala 1.45 (1^) 0.97 ( I p ) Leu 1.34 (H*) 1.22 (hp)
Arg (+) 0.79 (ia ) 0.90 (ip) Lys (+) 1.07 (la ) 0.74 (bp)
Asn 0.73 (ba ) 0.65 (bp) Met 1.20 (ha ) 1.67 (ty)
Asp ( - ) 0.98 (la ) 0.80 (ip) Phe 1.12 (ha ) 1.28 (hp)
Cys 0.77 Cia ) 1.30 (hp) Pro 0.59 (Ba ) 0.62 (bp)
Glu ( - ) 1.53 (H„) 0.26 ( B p ) Ser 0.79 (ia ) 1.20 (hp)
Gin 1.17 (ha ) 1.23 (hp) Thr 0.82 (ia ) 1.20 (hp)
Gly 0.53 (Ba ) 0.81 (ip) Trp 1.14 (ha ) 1.19 (hp)
His (+) 1.24 (ha ) 0.71 (bp) Tyr 0.61 (ba ) 1.29 (hp)
Me 1.00 (fa ) 1.60 (ty) Val 1.14 (ha ) 1.65 (ty)
Ha  — strong « former Hp — strong 8 former
ha — a former hp — $ former
la — weak a former Ip— weak p former
1a — indifferent a former ip — Indifferent P former
ba — a breaker bp — P breaker
Ba —  strong « breaker Bp - -  strong P breaker
Pro and Asp are assigned la  when at the N-terminus of a helix, and Arg is
assigned !a  when at the C-terminus of a helix. Trp is assigned bp when at
the C-terminus of a sheet region.
VITA
September 28, 
1964- 1972
1972 -  1976
1976- 1980
1980
1980
1986
1958 Born, Port Sulphur, Louisiana.
Attended McBride Academy, Port Sulphur, 
Louisiana.
Attended Delta Heritage Academy, Buras, 
Louisiana.
Attended Southeastern Louisiana University, 
Hammond, Louisiana.
Awarded a B.S. 1n Chemistry (major) and Zoology 
(minor).
Admitted to Louisiana State Univeristy, Baton 
Rouge, Louisiana.
Candidate for Ph.D. in Biochemistry, Louisiana 
State University, Baton Rouge, Louisiana.
163
DOCTORAL EXAMINATION AND DISSERTATION REPORT
Candidate: O l iv ia  S a lin o v ic h
Major Field: B iochem istry
Title of Dissertation: " C h a ra c te r iz a t io n  o f the  P ro te in  and G ly c o p ro te in  Components
from A n t ig e n ic a l ly  D is t in c t  S tra in s  o f Equine In fe c t io u s  
Anemia V iru s "
Approved:
Major Professor and Chairman
DlllJU *
ate feeDean of the Gradu Jschool
E X A M IN IN G  C O M M ITTE E :
^  X-)#L
Date of Examination:
A p r i l  29 , 1986
